CA2483654C - Wound therapy and tissue treatment management system and method with fluid differentiation - Google Patents
Wound therapy and tissue treatment management system and method with fluid differentiation Download PDFInfo
- Publication number
- CA2483654C CA2483654C CA 2483654 CA2483654A CA2483654C CA 2483654 C CA2483654 C CA 2483654C CA 2483654 CA2483654 CA 2483654 CA 2483654 A CA2483654 A CA 2483654A CA 2483654 C CA2483654 C CA 2483654C
- Authority
- CA
- Canada
- Prior art keywords
- gradient
- fluid
- transfer element
- wound
- zone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/77—Suction-irrigation systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/94—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with gas supply means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
Abstract
A wound therapy and tissue management system (2) utilizes fluid differentiation. Fluid is differentiated by establishing a gradient within the system (2). The gradient can be established with matter or energy. Patient interfaces (3) for establishing, maintaining and varying one or more gradients include transfer elements (8) with first (12) and second (18) zones having different flow coefficients. The transfer elements (8) exchange fluid with a patient, generally through a wound site (4), and with external components of the systems (2). Osmotic solution gradients are controlled by a methodology involving the present invention for extracting solutions, which can include toxins, from patients and for introducing fluids and sumping air to wound sites.
Description
, . woUND '1HERAPY A.ND TLSS TRF.A.TMF.N'x' GF.ME 9TF.M
AND IV,,_, THQDWITHFLMIITFk'EREi+PI'IATI4N
Da rkeraxtnd of the Igves+txot1 1. PieW of the Iaventiott.
The preseut invention relates generaily to medical.care, and. in particular to wound I0' therapy:and tissue management systcros.atxi methodologie9 with fluid dif#'erentiation.
AND IV,,_, THQDWITHFLMIITFk'EREi+PI'IATI4N
Da rkeraxtnd of the Igves+txot1 1. PieW of the Iaventiott.
The preseut invention relates generaily to medical.care, and. in particular to wound I0' therapy:and tissue management systcros.atxi methodologie9 with fluid dif#'erentiation.
2. Desaription of the Prior Art.
Heretofore, many wound tberapy and tissue marsagcmcnt devices and protocols have tended to focus on the addition or control of individual mechanir,al forccs and their respective effects on wound healing. For cxample, thc use of suction to secure skin graft dressings in p[ace is disclosed in 3ohnson, F.):., An Improved Technigue for Skin Gra~l Placement i'Jsing a Suction Arain; Surgery, Gynecology and Obstetrics 1984; 159 (G): 584-5. 4ther prior art devices have $ocused on thc application of compressive (9.e. positive or grtatcr-ihan-atmospheric) pressure to a wound site, the application of hcat and the delivcry of pharmacological agents.
Standard methods in the current praatice of wound cara rcauire changing the dressing in order to topically add pharmacological agents which require interval reapplication. Reapplications of pharnlacoIogicsl agents can be minimizcd or elitninated by using slow-release delivery systems.
However, such systems must generally be changed in their entireties in ordcr to change the agenis or dosagcs.
Another wound treatment protocol option involves dosing the etstirc patient, Agents are thereby dciivered systemicaily, Le. from within the patient, in order to furive at the wound site, as opposed to other protocols which dalivar respective agents externally or topically. However, systemic..medications m goncraliy adzninistercd In relativcly high doses In order to provide , . .
suftlcient corrcentratiom in affected areas and trcatment sites. Non-affected tissues and organs remote from the treatment sites thus tend to receiva concentrations of inedlcations from which they may not benefit.
Fluid management significantly affects many aspects of health care and is involved in many medical procedures. For example, wound care typically involves absorbingand/or drainitig wound exudates, blood, serum and other body fluids from the patient.
Surgical procedures often create wounds requiring tissue management and fluid drainage.
For example, skin grafts have exudates and bleeding that require management at both the donor and graft sites.
However, current tissue management and fluid drainage procedures are often ineffective in maintaining optimum moisture content for promoting wound healing. Excessive drying, on the one hand, can lead to desiccation, eschar formation and slowing of cell migration. Excessive moisture, on the other hand, can lead to maceration, bacterial overgrowth, tissue breakdown and necrosis.
Various types of porous, absorbent dressing materials have been used for dressing wounds to accumulate body fluids. 'The dressing materials facilitate drainage and also the collection and disposal of fluids. A disadvantage with many conventional dressings is that they require changing in order to reduce the risk of infection and to maintain effectiveness. However, dressing changes can add significantly to treatment costs and are associated with patient discomfort and medical risks such as infection and damage to reepithelialized tissues.
Accordingly, vacuum sources have been employed to drain wounds. For example, Zamierowski U.S.Patents No. 4,969,880; No. 5,100,396; No. 5,261,893; No. 5,527,293 and No.
6,071,267 pertain to wound dressings, fluid connections, fastening systems and medical procedures utilizing same in connection with vacuum-assisted wound drainage A wound drainage device using a hand-operated suction bulb is shown in the George et al. U.S. Patent No. 4,392,858. Motorized suction pumps can be employed to provide consistent, sub-atmospheric vacuum pressure for maintaining an effective drainage flow.
The Richmond et al. U.S. Patents No. 4,655,754 and No. 4,826,494 disclose vacuum wound drainage systems that can be connected to motorized vacuum pumps.
Another important objective in designing an effective wound drainage system is to provide an effective interface with the patient. Ideally, the patient interface should accommodate various types of wounds in different stages of recovery for as broad a range of applications as possible. As noted above, optimum wound healing generally involves maintaining a sufficient moisture level to avoid desiccation without causing the wound to macerate from excessive moisture. Sufficient moisture levels are required for epithelial cell migration, but excessive moisture can inhibit drying and maturation of the epithelial layer.
Pressures should be sufficient for effective drainage without creating excessive negative forces, which could cause pressure necrosis or separate freshly applied skin grafts.
Wound treatment procedures can also include infusing wound sites with liquids to flush contaminants, counter infection, promote healing growth and anesthetize the wound. Prior art fluid delivery systems include a device for treating tissues disclosed in the Svedman U.S. Patent No. 4,382,441; a product and process for establishing a sterile area of skin disclosed in the Groves U.S. Patent No. 3,367,332; and the transdermal infusion device disclosed in the Westin U.S. Patent No. 4,605,399. Equipment has also been available which flushes and collects contaminants from wounds.
Heretofore, there has not been available a system or methodology that allowed the manipulation of multiple mechanical forces affecting wound surfaces. Moreover, there has not previously been available a system or methodology that manipulated the gradients of gases, solids, liquids and medications in such a way as to provide the medical practitioner with various options for delivering the various agents either systematically from the patient side or topically from the external side of a wound. Further, there has not been available a system or methodology which affected the removal of toxins and undesirable byproducts by an external egress with the advantages and features of the present invention. Such advantages include minimizing or eliminating dressing changes whereby patient discomfort and infection risks are correspondingly reduced.
Heretofore, many wound tberapy and tissue marsagcmcnt devices and protocols have tended to focus on the addition or control of individual mechanir,al forccs and their respective effects on wound healing. For cxample, thc use of suction to secure skin graft dressings in p[ace is disclosed in 3ohnson, F.):., An Improved Technigue for Skin Gra~l Placement i'Jsing a Suction Arain; Surgery, Gynecology and Obstetrics 1984; 159 (G): 584-5. 4ther prior art devices have $ocused on thc application of compressive (9.e. positive or grtatcr-ihan-atmospheric) pressure to a wound site, the application of hcat and the delivcry of pharmacological agents.
Standard methods in the current praatice of wound cara rcauire changing the dressing in order to topically add pharmacological agents which require interval reapplication. Reapplications of pharnlacoIogicsl agents can be minimizcd or elitninated by using slow-release delivery systems.
However, such systems must generally be changed in their entireties in ordcr to change the agenis or dosagcs.
Another wound treatment protocol option involves dosing the etstirc patient, Agents are thereby dciivered systemicaily, Le. from within the patient, in order to furive at the wound site, as opposed to other protocols which dalivar respective agents externally or topically. However, systemic..medications m goncraliy adzninistercd In relativcly high doses In order to provide , . .
suftlcient corrcentratiom in affected areas and trcatment sites. Non-affected tissues and organs remote from the treatment sites thus tend to receiva concentrations of inedlcations from which they may not benefit.
Fluid management significantly affects many aspects of health care and is involved in many medical procedures. For example, wound care typically involves absorbingand/or drainitig wound exudates, blood, serum and other body fluids from the patient.
Surgical procedures often create wounds requiring tissue management and fluid drainage.
For example, skin grafts have exudates and bleeding that require management at both the donor and graft sites.
However, current tissue management and fluid drainage procedures are often ineffective in maintaining optimum moisture content for promoting wound healing. Excessive drying, on the one hand, can lead to desiccation, eschar formation and slowing of cell migration. Excessive moisture, on the other hand, can lead to maceration, bacterial overgrowth, tissue breakdown and necrosis.
Various types of porous, absorbent dressing materials have been used for dressing wounds to accumulate body fluids. 'The dressing materials facilitate drainage and also the collection and disposal of fluids. A disadvantage with many conventional dressings is that they require changing in order to reduce the risk of infection and to maintain effectiveness. However, dressing changes can add significantly to treatment costs and are associated with patient discomfort and medical risks such as infection and damage to reepithelialized tissues.
Accordingly, vacuum sources have been employed to drain wounds. For example, Zamierowski U.S.Patents No. 4,969,880; No. 5,100,396; No. 5,261,893; No. 5,527,293 and No.
6,071,267 pertain to wound dressings, fluid connections, fastening systems and medical procedures utilizing same in connection with vacuum-assisted wound drainage A wound drainage device using a hand-operated suction bulb is shown in the George et al. U.S. Patent No. 4,392,858. Motorized suction pumps can be employed to provide consistent, sub-atmospheric vacuum pressure for maintaining an effective drainage flow.
The Richmond et al. U.S. Patents No. 4,655,754 and No. 4,826,494 disclose vacuum wound drainage systems that can be connected to motorized vacuum pumps.
Another important objective in designing an effective wound drainage system is to provide an effective interface with the patient. Ideally, the patient interface should accommodate various types of wounds in different stages of recovery for as broad a range of applications as possible. As noted above, optimum wound healing generally involves maintaining a sufficient moisture level to avoid desiccation without causing the wound to macerate from excessive moisture. Sufficient moisture levels are required for epithelial cell migration, but excessive moisture can inhibit drying and maturation of the epithelial layer.
Pressures should be sufficient for effective drainage without creating excessive negative forces, which could cause pressure necrosis or separate freshly applied skin grafts.
Wound treatment procedures can also include infusing wound sites with liquids to flush contaminants, counter infection, promote healing growth and anesthetize the wound. Prior art fluid delivery systems include a device for treating tissues disclosed in the Svedman U.S. Patent No. 4,382,441; a product and process for establishing a sterile area of skin disclosed in the Groves U.S. Patent No. 3,367,332; and the transdermal infusion device disclosed in the Westin U.S. Patent No. 4,605,399. Equipment has also been available which flushes and collects contaminants from wounds.
Heretofore, there has not been available a system or methodology that allowed the manipulation of multiple mechanical forces affecting wound surfaces. Moreover, there has not previously been available a system or methodology that manipulated the gradients of gases, solids, liquids and medications in such a way as to provide the medical practitioner with various options for delivering the various agents either systematically from the patient side or topically from the external side of a wound. Further, there has not been available a system or methodology which affected the removal of toxins and undesirable byproducts by an external egress with the advantages and features of the present invention. Such advantages include minimizing or eliminating dressing changes whereby patient discomfort and infection risks are correspondingly reduced.
3 Effective control of fixation, temperature, pressure (and its associated gradients for vital gases such as oxygen), osmotic and oncotic forces, electrical and electromagnetic fields and forces and the addition and/or removal of various nutrients and pharmacological agents have not been achievable with the previous systems and methodologies. Still further, there has not been available a wound treatment system and methodology utilizing a transfer element for the manipulation of gas and liquid pathways under the control of pre-programmed, coordinated influx and efflux cycles. Such cycles are designed to maintain the desired integrity and stability of the system while still allowing variations in multiple forces, flows and concentrations within tolerated ranges. Previous wound treatments also tended to lack the dynamic and interactive features of the present invention whereby various gradients can be adjusted in response to patient wound site conditions. Such gradient adjustments can be accomplished with the present invention through the use of biofeedback loops and patient-responsive sensors.
Osmotic and concentration gradients provide an important mechanism for transferring various elements within the scope of the present invention. Such gradients occur naturally in living organisms and involve the movement of solutes from solutions with greater concentrations to solutions with lesser concentrations through semi-permeable membranes.
Osmosis is the tendency of solvents to pass through semi-permeable membranes into solutions of higher concentrations in order to achieve osmotic equilibrium. Diffusion occurs from an area of higher concentration or partial pressure to an area of lower concentration even without membrane separation. Examples include the diffusion transfer of oxygen from alveoli to capillaries within the lung and the osmotic transfer of toxins and waste within the kidneys from capillaries to tubules and on to the bladder. The systems and methods of the present invention utilize and control osmotic and diffusion gradients to advantage in treating wounds, particularly in connection with the removal of toxins in solution from wound sites by controlling fluids. The control of fluids originates both internally and externally. For example, wound exudates originate internally. External control fluids include sumped air, irrigation, etc.
Osmotic and concentration gradients provide an important mechanism for transferring various elements within the scope of the present invention. Such gradients occur naturally in living organisms and involve the movement of solutes from solutions with greater concentrations to solutions with lesser concentrations through semi-permeable membranes.
Osmosis is the tendency of solvents to pass through semi-permeable membranes into solutions of higher concentrations in order to achieve osmotic equilibrium. Diffusion occurs from an area of higher concentration or partial pressure to an area of lower concentration even without membrane separation. Examples include the diffusion transfer of oxygen from alveoli to capillaries within the lung and the osmotic transfer of toxins and waste within the kidneys from capillaries to tubules and on to the bladder. The systems and methods of the present invention utilize and control osmotic and diffusion gradients to advantage in treating wounds, particularly in connection with the removal of toxins in solution from wound sites by controlling fluids. The control of fluids originates both internally and externally. For example, wound exudates originate internally. External control fluids include sumped air, irrigation, etc.
4 Previous wound treatment systems and methodologies did not provide medical practitioners with the range of options available with the present invention for treating various patient circumstances and conditions.
Summary of the Invention In the practice of the present invention, a wound therapy and tissue management system is provided, which includes a collector assembly for attachment to a patient, a transfer assembly connected to the collector assembly and a gradient (e.g., negative pressure/vacuum, positive pressure, temperature, oxygen, etc.) source connected by suction tubing to the transfer assembly.
Thesystem is adaptable for use with various dressing assemblies, including multiple layers and components comprising hydrophobic and hydrophilic foam and sponge materials, semi-permeable and impermeable membranes applied as drapes, transfer system conduits and buffers, andtubular connections to pumps. Alternative embodiments of the system utilize osmotic gradients forcontrolling transfers and provide various optional configurations with internal and extetnal inputs, installation ports and other components. In the practice of the method of the present, invention, a fluid differentiation wound therapy and tissue management method is disclosed, which includes steps of shaping and applying a first sponge comprising a first sponge material to a wound area, applying a first drape, shaping and applying a second sponge comprising a second sponge material on top of the first drape and the first sponge, forming a fluid conduit and connecting same to the second sponge and to a buffer for ultimate connection to a vacuum pump. The conduit and the buffer are also draped. Osmotic wound therapy and tissue management methodologies are also discussed in connection with the present invention.
The transfer of fluids and substances such as toxins can be controlled through the application of such methodologies.
Summary of the Invention In the practice of the present invention, a wound therapy and tissue management system is provided, which includes a collector assembly for attachment to a patient, a transfer assembly connected to the collector assembly and a gradient (e.g., negative pressure/vacuum, positive pressure, temperature, oxygen, etc.) source connected by suction tubing to the transfer assembly.
Thesystem is adaptable for use with various dressing assemblies, including multiple layers and components comprising hydrophobic and hydrophilic foam and sponge materials, semi-permeable and impermeable membranes applied as drapes, transfer system conduits and buffers, andtubular connections to pumps. Alternative embodiments of the system utilize osmotic gradients forcontrolling transfers and provide various optional configurations with internal and extetnal inputs, installation ports and other components. In the practice of the method of the present, invention, a fluid differentiation wound therapy and tissue management method is disclosed, which includes steps of shaping and applying a first sponge comprising a first sponge material to a wound area, applying a first drape, shaping and applying a second sponge comprising a second sponge material on top of the first drape and the first sponge, forming a fluid conduit and connecting same to the second sponge and to a buffer for ultimate connection to a vacuum pump. The conduit and the buffer are also draped. Osmotic wound therapy and tissue management methodologies are also discussed in connection with the present invention.
The transfer of fluids and substances such as toxins can be controlled through the application of such methodologies.
5 The invention may be embodied in a fluid-differentiating wound therapy and tissue management system as follows. A fluid transfer element includes a patient contact surface, which may be non-attaching, and a first zone with a first fluid transfer coefficient. The fluid transfer element further includes a second zone with a second fluid transfer coefficient different from the first fluid transfer coefficient, the second zone being located adjacent to the first zone.
The fluid transfer element further includes a predetermined fluid flow path through the element guided by the fluid transfer coefficient differential between the first and second zones. A cover is placed over the transfer element in contact therewith and is adapted for contact with the patient, which may include adhesive adapted for adhering the cover to the patient, around the perimeter of the fluid transfer element. The system further includes a gradient source for creating a gradient, which may be an oncotic gradient, across the transfer element whereby fluids may be moved through the transfer element. An effluent conduit is connected to the transfer element and is adapted for discharging effluent from the system. The predetermined fluid flow path may be toward the effluent conduit.
Brief Description of the Drawings Fig. 1 is a block diagram of a vacuum-fixed wound therapy system embodying the present invention.
5a Fig.2 is a perspective view of a composite dressing assembly.
Fig.3 is a vertical cross-sectional view of the dressing assembly taken generally along line 3-3 in Fig.2.
Fig.4 is an enlarged, fragmentary, cross-sectional view of a composite dressing comprising a first modified embodiment of the present invention.
Fig.5 is a perspective view of a composite dressing comprising a second modified embodiment of the present invention.
Fig. 5a is a perspective view of a variation of the embodiment shown in Fig.
5.
Fig. 6 is a perspective view of a transfer assembly for a composite dressing comprising a third modified embodiment of the present invention.
Fig. 7 is a cross-sectional view of a third modified embodiment composite dressing.
Fig. 8 is a perspective view of the third modified embodiment composite dressing.
Fig. 9 is a perspective view of a composite dressing comprising a fourth modified embodiment of the present invention.
Fig. 10 is a flow diagram of a vacuum-fixed wound therapy method embodying the present invention.
Fig. 11 is an exploded view of a wound treatment system with vacuum, heat and fluid assistance.
Fig.12 is an exploded view of another wound treatment system with vacuum, heat and fluid assistance.
Fig. 13 is an exploded view of yet another wound treatment system with vacuum, heat and fluid assistance.
Figs. 14a-d comprise graphs showing the temperature-elevating performance of the wound treatment systems shown in Figs 11-13.
Fig. 15 is a block diagram of a wound therapy and tissue management system comprising an eighth alternative embodiment of the present invention.
The fluid transfer element further includes a predetermined fluid flow path through the element guided by the fluid transfer coefficient differential between the first and second zones. A cover is placed over the transfer element in contact therewith and is adapted for contact with the patient, which may include adhesive adapted for adhering the cover to the patient, around the perimeter of the fluid transfer element. The system further includes a gradient source for creating a gradient, which may be an oncotic gradient, across the transfer element whereby fluids may be moved through the transfer element. An effluent conduit is connected to the transfer element and is adapted for discharging effluent from the system. The predetermined fluid flow path may be toward the effluent conduit.
Brief Description of the Drawings Fig. 1 is a block diagram of a vacuum-fixed wound therapy system embodying the present invention.
5a Fig.2 is a perspective view of a composite dressing assembly.
Fig.3 is a vertical cross-sectional view of the dressing assembly taken generally along line 3-3 in Fig.2.
Fig.4 is an enlarged, fragmentary, cross-sectional view of a composite dressing comprising a first modified embodiment of the present invention.
Fig.5 is a perspective view of a composite dressing comprising a second modified embodiment of the present invention.
Fig. 5a is a perspective view of a variation of the embodiment shown in Fig.
5.
Fig. 6 is a perspective view of a transfer assembly for a composite dressing comprising a third modified embodiment of the present invention.
Fig. 7 is a cross-sectional view of a third modified embodiment composite dressing.
Fig. 8 is a perspective view of the third modified embodiment composite dressing.
Fig. 9 is a perspective view of a composite dressing comprising a fourth modified embodiment of the present invention.
Fig. 10 is a flow diagram of a vacuum-fixed wound therapy method embodying the present invention.
Fig. 11 is an exploded view of a wound treatment system with vacuum, heat and fluid assistance.
Fig.12 is an exploded view of another wound treatment system with vacuum, heat and fluid assistance.
Fig. 13 is an exploded view of yet another wound treatment system with vacuum, heat and fluid assistance.
Figs. 14a-d comprise graphs showing the temperature-elevating performance of the wound treatment systems shown in Figs 11-13.
Fig. 15 is a block diagram of a wound therapy and tissue management system comprising an eighth alternative embodiment of the present invention.
6 Fig. 1.6 is a schematic diagram of the. eighth alternative embodiment wound therapy and tissue management system.
Fig. 17 is a flowchart of a wound and therapy and tissue management methodology embodying the present invention.
Fig. 18 is a block diagram of a wound therapy and tissue management system comprising a ninth alternative by the present invention. Fig. 19 is a diagram showing various phases in a hyperosmolar or air-sump system embodying the present invention.
Fig. 20 is a diagram showing various phases in an osmolar or isotonic flush or rinse system embodying the present invention.
Fig. 21 is a diagram showing a hypo-osmolar or heavy drape system embodying the present invention.
Detailed Description of the Preferred Embodiments 1. Introduction and Environment.
As required, detailed embodiments of the present invention are disclosed herein;
however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure.
II. Vacuum-fixed Wound Therapy Dressing 3.
Referring to the drawings in more detail, the reference numeral 2 generally designates a vacuum-fixed wound therapy system for application to a wound 4 on or in a patient 5. The system 2 includes an improved dressing 3. Other components of the system 2 are described in my U.S. Patent No. 6,071,267, _ The dressing 3 generally includes a collector assembly 6 and a transfer assembly 8 connected to a vacuum source 10. The collector assembly 6 includes a first sponge 12
Fig. 17 is a flowchart of a wound and therapy and tissue management methodology embodying the present invention.
Fig. 18 is a block diagram of a wound therapy and tissue management system comprising a ninth alternative by the present invention. Fig. 19 is a diagram showing various phases in a hyperosmolar or air-sump system embodying the present invention.
Fig. 20 is a diagram showing various phases in an osmolar or isotonic flush or rinse system embodying the present invention.
Fig. 21 is a diagram showing a hypo-osmolar or heavy drape system embodying the present invention.
Detailed Description of the Preferred Embodiments 1. Introduction and Environment.
As required, detailed embodiments of the present invention are disclosed herein;
however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure.
II. Vacuum-fixed Wound Therapy Dressing 3.
Referring to the drawings in more detail, the reference numeral 2 generally designates a vacuum-fixed wound therapy system for application to a wound 4 on or in a patient 5. The system 2 includes an improved dressing 3. Other components of the system 2 are described in my U.S. Patent No. 6,071,267, _ The dressing 3 generally includes a collector assembly 6 and a transfer assembly 8 connected to a vacuum source 10. The collector assembly 6 includes a first sponge 12
7 comprising a hydrophilic material, such as polyvinyl alcohol (PVA). The first sponge 12 is cut to generally conform to the size of the wound 4. A first sponge drape 14 is placed over the first sponge 12 and an opening 16 is formed in the drape 14 and is preferably sized smaller than the first sponge 12. The drape 14 encloses a compression chamber 15 containing the first sponge 12. A dry skin, moisture-control zone 17 is formed around the first sponge 12 due to air circulation within the compression chamber 15 and promotes healing.
A second sponge 18, preferably comprising a hydrophobic polyurethane ether (PUE) material is sized larger than the first sponge 12, whereby a second sponge overhang 20 extends beyond the perimeter of the first sponge 12. A second sponge drape 22 is placed over the second sponge 18 and includes an opening 241ocated along an outer edge 26 of the second sponge 18 for directing the outflow of fluid effluent from the collector assembly 6.
The transfer assembly 8 includes a conduit 28, which can comprise the same hydrophobic material as the second sponge 18. The conduit 28 includes an inlet end 30 which is offset in order to overlie the second sponge drape opening 24 along the second sponge outer edge 26. A conduit outlet end 32 mounts a buffer 34, which also preferably comprises the hydrophobic foam and projects outwardly from the conduit 28 and receives a suction tube 36 which is also connected to the vacuum source (e.g., pump) 10. A conduit drape 38 overlies the conduit 28 and includes an opening 40, which receives the buffer 34. A buffer drape 42 includes a first panel 42a and a second panel 42b, which are secured together over the buffer 34 and the suction tube 36 to enclose same. The buffer drape first and second panels 42a,b are mounted on the conduit drape 38 around the opening 40 therein.
In operation, the hydrophilic first sponge 12 tends to collapse under negative pressure.
Therefore, the size of the first sponge 12 is limited and it is preferably mounted in proximity to an edge 26 of the second sponge 18. The second sponge 18 cooperates with the transfer assembly to distribute the negative pressure throughout the hydrophobic second sponge 18 and in turn throughout the first sponge 12. The PVA material comprising the first sponge 12 permits
A second sponge 18, preferably comprising a hydrophobic polyurethane ether (PUE) material is sized larger than the first sponge 12, whereby a second sponge overhang 20 extends beyond the perimeter of the first sponge 12. A second sponge drape 22 is placed over the second sponge 18 and includes an opening 241ocated along an outer edge 26 of the second sponge 18 for directing the outflow of fluid effluent from the collector assembly 6.
The transfer assembly 8 includes a conduit 28, which can comprise the same hydrophobic material as the second sponge 18. The conduit 28 includes an inlet end 30 which is offset in order to overlie the second sponge drape opening 24 along the second sponge outer edge 26. A conduit outlet end 32 mounts a buffer 34, which also preferably comprises the hydrophobic foam and projects outwardly from the conduit 28 and receives a suction tube 36 which is also connected to the vacuum source (e.g., pump) 10. A conduit drape 38 overlies the conduit 28 and includes an opening 40, which receives the buffer 34. A buffer drape 42 includes a first panel 42a and a second panel 42b, which are secured together over the buffer 34 and the suction tube 36 to enclose same. The buffer drape first and second panels 42a,b are mounted on the conduit drape 38 around the opening 40 therein.
In operation, the hydrophilic first sponge 12 tends to collapse under negative pressure.
Therefore, the size of the first sponge 12 is limited and it is preferably mounted in proximity to an edge 26 of the second sponge 18. The second sponge 18 cooperates with the transfer assembly to distribute the negative pressure throughout the hydrophobic second sponge 18 and in turn throughout the first sponge 12. The PVA material comprising the first sponge 12 permits
8 it to compress under a negative pressure gradient. Moreover, because the fluid travel distance in the first sponge 12 tends to be relatively short due to its composition, the overlying second sponge 18 tends to distribute the negative pressure gradient relatively evenly across substantially the entire area of the first sponge 12.
The PUE composition of the second sponge 18 provides a reticulated latticework or weave which resists compression and includes relatively open passages to facilitate fluid flow.
Although such open-lattice construction has operational advantages, the passages formed thereby in the second sponge 18 tend to receive "spicule" penetrations from the wound, which is undesirable in many applications. Therefore, the collector assembly 6 is constructed by first forming the first sponge 12 to generally conform to the wound 4, whereafter the second sponge 18 is formed to provide the overhang 20. The first sponge 12 is covered with the first sponge drape 14, the opening 16 of which is normally sized smaller than the overall area of the first sponge 12.
The functional advantages of the collector assembly 6 construction include optimizing compression and fixation and edema control at the wound edge while maximizing the air-induced drying of the intact skin in the dry skin zone 17. Moreover, collector assemblies and transfer assemblies can be mixed and configured in a wide variety of arrangements to accommodate various patient conditions. For example, multiple transfer assemblies 8 can be connected to a single collector assembly 6 and vice versa.
III. First Modified Embodiment Fluid Differentiating Wound Dressing 53.
A wound dressing 53 comprising a first modified embodiment of the present invention is shown in Fig.4 and includes a liner 54 between the wound 4 and a first sponge 56, which can comprise a hydrophilic or hydrophobic material. The liner 54 passes fluid, but partially isolates and shields the wound tissue from the first sponge 56 to prevent the formation of spicules
The PUE composition of the second sponge 18 provides a reticulated latticework or weave which resists compression and includes relatively open passages to facilitate fluid flow.
Although such open-lattice construction has operational advantages, the passages formed thereby in the second sponge 18 tend to receive "spicule" penetrations from the wound, which is undesirable in many applications. Therefore, the collector assembly 6 is constructed by first forming the first sponge 12 to generally conform to the wound 4, whereafter the second sponge 18 is formed to provide the overhang 20. The first sponge 12 is covered with the first sponge drape 14, the opening 16 of which is normally sized smaller than the overall area of the first sponge 12.
The functional advantages of the collector assembly 6 construction include optimizing compression and fixation and edema control at the wound edge while maximizing the air-induced drying of the intact skin in the dry skin zone 17. Moreover, collector assemblies and transfer assemblies can be mixed and configured in a wide variety of arrangements to accommodate various patient conditions. For example, multiple transfer assemblies 8 can be connected to a single collector assembly 6 and vice versa.
III. First Modified Embodiment Fluid Differentiating Wound Dressing 53.
A wound dressing 53 comprising a first modified embodiment of the present invention is shown in Fig.4 and includes a liner 54 between the wound 4 and a first sponge 56, which can comprise a hydrophilic or hydrophobic material. The liner 54 passes fluid, but partially isolates and shields the wound tissue from the first sponge 56 to prevent the formation of spicules
9 penetrating the open-passage first sponge 56. The liner 54 thus permits the first sponge 56 to comprise hydrophobic (e.g., PUE) material, even when spicule penetration is not desired.
IV. Second Modified Embodiment Fluid Differentiating Wound Dressing 102.
A wound dressing comprising a second modified embodiment of the present invention is shown in Fig. 5 and generally comprises a collector assembly 106 and a transfer assembly 108.
The collector assembly 106 can be similar to the collector assembly 6 with a suitable composite construction. The transfer assembly 108 comprises an elbow connector 110 placed on top of a second sponge drape 112 covering the second sponge 114. The elbow connector 110 mounts the distal end 116 of a suction tube 118, which is also connected to a vacuum source 10. A first sponge drape 120 is placed over a first, hydrophilic sponge 122 and includes a central opening 123 communicating with the second sponge 114.
Fig. 5a shows an interface device 102a comprising a variation of the construction of the wound dressing 102. The device 102a utilizes a flexible, bellows-type tubing section 110a in place of the elbow connector 110 described above. A needle-free, leur lock hub 124a is mounted on the end of the tubing section I l0a and functions as an injection port. It will be appreciated that the sponge 122 can be omitted from the dressing 102a whereby same can be used as a fluid inlet or outlet in various applications and on many different configurations of dressings.
V. Third Modified Embodiment Fluid Differentiating Wound Dressing 202.
A fluid differentiating wound dressing 202 comprising a third modified embodiment of the present invention is shown in Figs.6-8 and generally comprises a transfer assembly 204 (Fig.6) adapted for mounting on a collector assembly 206 as shown in Fig.7.
The transfer assembly 204 comprises a sponge material buffer 208 which can comprise, for example, polyurethane ether (PUE). The buffer 208 is encased in first and second drape panels 210, 212 with wings 210a, 212a respectively extending in opposite directions from the buffer 208. The wings 210a, 212a have an adhesive layer 214, which is covered by a removable backing sheet 216 prior to installation. Tab strips 218 are provided at the ends of the drape wings 210a, 212a. The tab strips 218 are attached by perforated lines 220 for easy removal upon installation. The suction tube 36 is embedded in the buffer 208 and extends outwardly from the transfer assembly 204 from between the first and second drape panels 210, 212.
An optional leur-lock hub 213 is mounted on the end of the tube 36 for injection port applications.
The transfer assembly 204 is adapted for mounting on a collector assembly 206 (Fig.7), which is similar to the collector assembly 6 described above. An opening 224 is formed in a second drape 222 which overlies a second sponge 218. With the backing sheet 216 peeled away, the adhesive layer 214 on the drape panel wings 210a, 212a secures the transfer assembly 204 in place whereby the buffer 208 is in communication with the second sponge 218 through the opening 224. An optional first sponge 212 can be placed on the wound 4 and covered with drape 214 with an opening 216 formed therein. The dressing 202 can also be utilized with a single sponge for the collector assembly 206.
Fig. 8 shows an application of the dressing 202 wherein the transfer assembly 204 is mounted over a medial or interior portion 218a of the second sponge 218. A
first end 208a of the buffer 208 can be folded substantially flat on top of the second drape which overlies the second sponge 18. A second end 208b of the buffer 208 extends outwardly from the collector assembly 206. The buffer 208 can flex in response to pulling forces tugging on the suction tube 236. The dressing 202 as shown in Fig. 8 is wrapped with drape strips 222, which are adapted for encircling an extremity of a patient. Thus, the buffer first end 208a is secured by a drape strip 222 as shown. The drape strips 222 can be utilized for applying a compressive force to the dressing 202. In operation, evacuating the dressing 202 causes portions of it to shrink, compress and collapse under the pressure gradient, thus providing a visual indication of its performance.
VI. Fourth Modified Embodiment Fluid Differentiating Wound Dressing 302.
Fig.9 shows a fluid differentiating wound dressing 302 comprising a fourth modified embodiment of the present invention. The dressing 302 includes a collector assembly 304 and a transfer assembly 306. The collector assembly 304 includes first and second sponges 308, 310.
The first sponge 308 is mounted on the wound and can comprise, for example, a hydrophilic foam material as described above. The second sponge 310 can be mounted directly on the first sponge 308 (optionally separated by a drape) and can receive a tube 312 connected to a vacuum source. The second sponge 310 can include an overhang 313 extending beyond the first sponge 308 for providing a compression chamber 315 as described above. A drape 314 is placed over the collector assembly 304 and the tube 312. The drape 314 is folded over the tube 312 whereby same is spaced outwardly from the skin, thus providing an effective, fluid-tight seal around the tube 312., VII. Vacuum-Fixed Wound Therapy Method.
Fig. 10 shows a wound therapy method embodying the present invention. The method can be performed with one or more of the systems discussed above, including the vacuum-fixed dressings 3, 53, 102, 202 and 302. The method can also be performed with a wide variety of variations on the systems and dressings disclosed above.
VII. Fifth Modified Embodiment Wound Therapy And Tissue Management System 402.
Fig. 11 shows a wound therapy and tissue management system 402 comprising a fifth modified embodiment of the present invention. The system 402 includes a dressing 404 placed on a wound 406. Any of the dressing systems discussed above can be utilized.
The enclosure 414 is placed over the wound site 406 and includes an opening 416 extending therethrough and adapted for receiving a warming card 418 in covering relation thereover. The warming card 418 is operationally connected to a temperature control unit 420. A vacuum assisted closure unit 408 is fluidically connected to the enclosure 414 by a suitable suction tube and in turn is connected to a power source 410.
In operation, the warming card 418 is heated and raises the temperature within the enclosure 414 to promote healing. The vacuum assisted closure 408 functions as described above to remove effluent and to promote healing in cooperation with the warming card 418.
Warming cards and other components for use in connection with this embodiment of the invention are available from Augustine Medical Products, Inc.
IX. Sixth Modified Embodiment Wound Therapy and Tissue Management System 502.
Fig. 12 shows a wound therapy and tissue management system 502 comprising a sixth modified embodiment of the present invention. The system 502 is similar to the system 402 described above. A composite dressing 504 is comprised of first and second layers 506, 508. A
fluid source 518 communicates with a temperature control and pump unit 514 and provides influx to the system 502.
X. Seventh Modified Embodiment Wound Therapy and Tissue Management System 602.
Fig. 13 shows a wound therapy and tissue management system 602 comprising a seventh modified embodiment of the present invention. The system 602 is similar to the systems 402 and 502 described above. A transfer element 604 is covered by a drape 620, which mounts a film 616 adapted for receiving a warming card 618.
XI. Test Data Figs.14a-14d shows the results of tests performed with the dressing systems and methodologies discussed above and variations thereon. Fig. 14a shows system performance (time and temperature) with a dry PUE hydrophobic sponge material. Fig. 14b shows system performance with a wet PVA hydrophilic sponge material. Fig. 14c shows performance with an irrigated PUE hydrophobic sponge material with a warm-up plate (heating card) and a cover.
Fig. 14d shows system performance with both PUE hydrophobic sponge material and PVA
hydrophilic sponge material.
XII. Wound Therapy and Tissue Management System 702.
Figs. 15 and 16 show a wound therapy and tissue management system 702 comprising an eighth modified embodiment of the present invention. The system 702 is shown schematically in Fig. 15 and consists of inputs 704, the patient 706, outputs 708 and a feedback loop 710. The inputs 704 can comprise virtually any matter or energy deemed appropriate for the treatment protocol by the health-care practitioner. For example, various irrigation fluids, growth factors, antibiotics, anesthetics, etc. can be input to the patient 706. Still further, the inputs can comprise various forces and energy forms whereby a matter/energy gradient is established with respect to the patient 706.
For example, negative pressure from a suitable vacuum source (such as a VAC
unit available from Kinetic Concepts, Inc. of San Antonio, Texas) can be an input for creating a negative pressure gradient across the system. Likewise, positive pressure from a suitable fluid pump can be input to establish a positive pressure gradient across the system.
Other forces can provide electromagnetic, electrical, mechanical and thermal gradients.
The system 702 monitors performance of the patient 706 and controls the inputs interactively in response thereto. Parameters which could be monitored for feedback purposes included moisture levels, temperature, bacteria levels, fluid pressure, etc.
The presence or absence of particular elements and compounds can also be sensed, monitored and acted upon.
For example, is widely known that oxygen is an important factor in wound healing. Studies have shown that reepithelialization and collagen production are best achieved by varying the oxygen supply. Thus, the oxygen level within the enclosed, wound site environment can be monitored and the oxygen levels therein either increased or decreased as necessary to promote healing. Other controllable parameters include the pH factor and the moisture concentration of the wound environment. Various suitable monitoring means can be employed, including electronic sensors, visual indicators, color-change substances, etc.
The output from the patient can consist of fluid, such as effluent from the wound site, irrigation fluid removed in the process of flushing the wound site, and other matter and energy.
An important function of the system is the removal of toxins and bacteria, which can be flushed from the wound site in a liquid or fluid solution.
Fig. 16 is a block diagram of the system 702, showing the components thereof in greater detail. A programmable controller 712 can be preprogrammed to operate the system according to predetermined protocols. The controller 712 is connected to and controls the operation of the input source 714 and the gradient source 716. The input source 714 can comprise any suitable matter or energy for input to the system 702, including various fluids, medications, thermal energy, mechanical forces, temperature, etc., as discussed above. The gradient source is likewise unlimited. For example, pressure gradients (both positive and negative) are particularly suitable for controlling the operation of the system 702 for draining wounds.
Other types of gradients include temperature, osmotic, oncotic, pH, oxygen demand, bacteria concentrations, etc., as discussed above.
A gradient source 716 can comprise any suitable device for establishing a gradient. For example, a vacuum source can be utilized for creating a negative pressure gradient. A pump can be utilized for creating a positive pressure gradient. A drape 718 is placed in covering relation over a transfer element 720. The drape 718 can comprise any of the film materials discussed above and can be permeable, semi-permeable or impervious.
The transfer element 720 includes a first zone 720a with a first set of fluid flow characteristics and a second zone 720b with a second set of fluid flow characteristics. Such fluid flow characteristics can be a function of material, thickness, porosity, permeability, and sponge material attraction to proteins, fat cells and other substances. The zones 720a,b can be formed by providing layers of the material, by providing varying thicknesses, by interspersing a first material within a second material in predetermined configurations, etc. Still further, the first and second zones can be formed by subjecting the transfer element 720 to an electromagnetic field.
The first and second zones 7 20a,b can also be formed by varying the density of the transfer element 720, as indicated by the dashed line 732 (Fig. 16). Line 732 represents compressed material (e.g., foam) along one edge and expanded material in the second zone 720b. Such density gradients can be achieved by compressing the material or by heat-setting same in a manufacturing process. Transfer element 720 edges can also be compressed when the dressing is applied to achieve a desired density gradient. Material thickness can also be utilized to provide a flow coefficient gradient. In this case line 732 could represent a tapering of the transfer element 720 across the first and second zones 720a, 720b. A marbling effect with a material concentration gradient is shown at 733, with greater concentration along an edge and decreasing concentration towards interior portions of the transfer element 720, or vice-versa.
Constructing the first and second zones 720a, 720b of different materials with different respective flow coefficients could also achieve a desired flow gradient.
Medications and other substances can be applied to the transfer element materials to alter the flow characteristics thereof. Systemic agents 731 can be administered to the patient 726.
Fluid 722 can be introduced into the wound site 724 from the inputs 714 and its flow pathways can be controlled by the gradient source 716. For example, sponge materials with different flow characteristics can be configured to direct fluid (either gas or liquid) in predetermined flow patterns through the transfer element 720. Effluent 728 from the patient 726 is withdrawn from the wound site 724 and evacuated to a collection receptacle 730.
XII. Wound Therapy and Tissue Management Methodology Fig. 17 shows a flowchart for a wound therapy and tissue management methodology embodying the president mentioned. From Start 804, the method proceeds to Diagnose Patient Condition 806. Based on the diagnosis, a treatment protocols selected. The protocol includes an identification of gradients to be controlled by the methodology. For example, protocols involving vacuum-assisted wound drainage will generally include a negative pressure gradient.
Additional possible gradients are discussed above. It will be appreciated that virtually unlimited combinations of gradients can be formed in the system 702. Moreover, the timing of the gradient control can be varied as needed to achieve desired treatment results.
For example, collagen production and reepithelialization can be promoted by hyperbaric oxygen treatment procedures, such as alternating elevated and reduced oxygen concentrations.
Suction/compressive pressures can also be alternated to stimulate tissue growth.
Gradient sources are provided at 810 and can comprise vacuum/suction, fluids, medications, oxygen and various other matter and energy. Gradients can also be formed utilizing energy sources, such as thermal, mechanical force, etc. First and second transfer characteristics are selected at 812, 814 respectively. A transfer element(s) is provided at 816 and includes the transfer characteristics selected at 812, 814. The patient is prepared at 818.
Patient preparations can include any suitable medical procedures, such as debriding the wound, etc.
The transfer element is applied at 820 and draped at 822. The transfer element is connected to a gradient source at 824 and the gradient is applied at 826.
Fluid is transferred through the first transfer element zone at 828 and through the second transfer element zone at 830. It will be appreciated that such transfer zones can be adapted for directing the fluid along certain pathways to achieve desired results, such as evacuation of exudates.
The fluid is differentiated (e.g., liquids, gases or liquids and gases are separated) at 832.
The operating parameters are monitored at 834 and the gradient source(s) are adjusted accordingly add 836. Thereafter a"Continue?" decision box 838 is reached. If affirmative, the method returns to Apply Gradient 826 and operation continues with the adjusted gradient parameters. A negative decision at 838 leads to a termination of the procedure (i.e., "End") at 840.
XIV. Osmotic Gradient Wound Therapy and Tissue Management System 902 and Methodology.
Figs. 18-21 show a wound therapy and tissue management system 902 and methodology utilizing a controlled osmotic gradient. A patient 904 includes capillaries 906 which provide fluid, such as serum and blood, to a wound 908. Such fluid passes to the transfer element 910.
An air sump contro1914 communicates with the transfer element 910 through an air sump conduit 912. A discharge contro1918 communicates with the transfer element 910 through a discharge conduit 916. The controls 914,918 are interactively controlled by a controller 922, which is adapted to receive control input signals. Such input signals can comprise, for example, preprogrammed inputs, feedback signals (Fig. 15), etc. The input signals can origiiiate at sensors associated with the system 902 and with the patient 904. Such inputs can effectively conirol the osmotic gradient to achieve desired fluid, solvent and solute (e.g., toxin) transfers. For example, the primary external substance input can comprise:relatively dry ambient air.
Air movement through the system 902 tends to collect moisture for. discharge as water vapor.
The system 902 is covered by a drape 920, which can comprise various semi-permeable and impervious materials as required by fluid flow considerations and,various applications. For example, an impervious drape 920 tends -to block air from the system 902 and permit entry of same only through the air sump control 914.
Fig. 19 shows a hyperosmolar or air-sump system. Phase 1 represents a steady-state or increasing-toxin A condition and a concomitant increasing movement of toxin A
back into the patient. In phase 2 a hyperosmolar solution or air sump is introduced. This gradient draws fluid 15, from the capillaries to replace the fluid moved out of the wound into the transfer element carrying toxin A with it and decreasing movement of toxin A into the patient..
Alternatively or in addition; warmed irrigating fluid can be introduced into the -transfer element in phase 2. The advantages of warming the transfer element and wound site.in this manner include vasodilation, increase in cell motility and an increase in phagocytosis. For example, irrigating fluid warmed to approximately 40 degrees centigrade has been shown to remove the inhibitory effect of chronic wound fluid on cell culture motility and proliferation.
In phase 3, ongoing administration of this gradient continues these fluxes as water vapor is removed and dry air is sumped. Phase 4 results in a new steady-state condition with lower levels of toxin A in the wound (and the patient) and increased fluid and toxin A in the transfer element that is continuously evacuated.
Fig. 20 shows an isosmatic or isotonic flush or rinse methodology. In phase 1 there is a steady-state (or increasing toxin A level) condition with fluid (liquids) moving out from the wound to the transfer element being replaced by serum exudate from the capillary.
Evaporative loss from the transfer element is kept to a minimum by application of a drape material.
In phase 2, an isomatic rinse is introduced increasing the fluid content of the transfer element and decreasing the concentration of toxin A enabling a diffusion of toxin A from the wound into the transfer element. In phase 3, as this fluid is withdrawn, it also removes toxin A, enabling a continued diffusion of toxin A out of the wound. In phase 4, the resulting condition is fluid equilibrium and decreased concentration of toxin A in the wound.
As this situation revers to phase 1, the flush or rinse is repeated at intervals.
Fig. 21 shows a hypo-osmolar or heavy drape system. In phase 1 steady-state conditions generally exist with some evaporative loss of fluid (water vapor).
In phase 2, small amounts of hypo-osmolar fluid are introduced, or a cover/drape is placed over the transfer element with a heavy drape completely blocking evaporative loss, thus adding "free water" to the system. This reverses the outward flow of fluid from the wound.
In phase 3 this increased fluid in the wound allows the total amount of toxin A to also accumulate in the wound. In phase 4 this increase of fluid and toxin A in the wound without any egress produces movement of fluid (edema) and toxins (cellulitis) back into the patient and into the lumphatics.
Conclusion It is to be understood that while certain forms of the present invention have been illustrated and described herein, it is not to be limited to the specific forms or arrangement of parts described and shown.
Furthermore, it should be appreciated that divisional applications depending from this specification may be pending at the time this patent issues, the claims of which may encompass embodiments and applications not encompassed by the claims appended herein.
Accordingly, embodiments or elements disclosed in the specification but not literally claimed in the appended claims, if any, should not be presumed to be dedicated to the public.
IV. Second Modified Embodiment Fluid Differentiating Wound Dressing 102.
A wound dressing comprising a second modified embodiment of the present invention is shown in Fig. 5 and generally comprises a collector assembly 106 and a transfer assembly 108.
The collector assembly 106 can be similar to the collector assembly 6 with a suitable composite construction. The transfer assembly 108 comprises an elbow connector 110 placed on top of a second sponge drape 112 covering the second sponge 114. The elbow connector 110 mounts the distal end 116 of a suction tube 118, which is also connected to a vacuum source 10. A first sponge drape 120 is placed over a first, hydrophilic sponge 122 and includes a central opening 123 communicating with the second sponge 114.
Fig. 5a shows an interface device 102a comprising a variation of the construction of the wound dressing 102. The device 102a utilizes a flexible, bellows-type tubing section 110a in place of the elbow connector 110 described above. A needle-free, leur lock hub 124a is mounted on the end of the tubing section I l0a and functions as an injection port. It will be appreciated that the sponge 122 can be omitted from the dressing 102a whereby same can be used as a fluid inlet or outlet in various applications and on many different configurations of dressings.
V. Third Modified Embodiment Fluid Differentiating Wound Dressing 202.
A fluid differentiating wound dressing 202 comprising a third modified embodiment of the present invention is shown in Figs.6-8 and generally comprises a transfer assembly 204 (Fig.6) adapted for mounting on a collector assembly 206 as shown in Fig.7.
The transfer assembly 204 comprises a sponge material buffer 208 which can comprise, for example, polyurethane ether (PUE). The buffer 208 is encased in first and second drape panels 210, 212 with wings 210a, 212a respectively extending in opposite directions from the buffer 208. The wings 210a, 212a have an adhesive layer 214, which is covered by a removable backing sheet 216 prior to installation. Tab strips 218 are provided at the ends of the drape wings 210a, 212a. The tab strips 218 are attached by perforated lines 220 for easy removal upon installation. The suction tube 36 is embedded in the buffer 208 and extends outwardly from the transfer assembly 204 from between the first and second drape panels 210, 212.
An optional leur-lock hub 213 is mounted on the end of the tube 36 for injection port applications.
The transfer assembly 204 is adapted for mounting on a collector assembly 206 (Fig.7), which is similar to the collector assembly 6 described above. An opening 224 is formed in a second drape 222 which overlies a second sponge 218. With the backing sheet 216 peeled away, the adhesive layer 214 on the drape panel wings 210a, 212a secures the transfer assembly 204 in place whereby the buffer 208 is in communication with the second sponge 218 through the opening 224. An optional first sponge 212 can be placed on the wound 4 and covered with drape 214 with an opening 216 formed therein. The dressing 202 can also be utilized with a single sponge for the collector assembly 206.
Fig. 8 shows an application of the dressing 202 wherein the transfer assembly 204 is mounted over a medial or interior portion 218a of the second sponge 218. A
first end 208a of the buffer 208 can be folded substantially flat on top of the second drape which overlies the second sponge 18. A second end 208b of the buffer 208 extends outwardly from the collector assembly 206. The buffer 208 can flex in response to pulling forces tugging on the suction tube 236. The dressing 202 as shown in Fig. 8 is wrapped with drape strips 222, which are adapted for encircling an extremity of a patient. Thus, the buffer first end 208a is secured by a drape strip 222 as shown. The drape strips 222 can be utilized for applying a compressive force to the dressing 202. In operation, evacuating the dressing 202 causes portions of it to shrink, compress and collapse under the pressure gradient, thus providing a visual indication of its performance.
VI. Fourth Modified Embodiment Fluid Differentiating Wound Dressing 302.
Fig.9 shows a fluid differentiating wound dressing 302 comprising a fourth modified embodiment of the present invention. The dressing 302 includes a collector assembly 304 and a transfer assembly 306. The collector assembly 304 includes first and second sponges 308, 310.
The first sponge 308 is mounted on the wound and can comprise, for example, a hydrophilic foam material as described above. The second sponge 310 can be mounted directly on the first sponge 308 (optionally separated by a drape) and can receive a tube 312 connected to a vacuum source. The second sponge 310 can include an overhang 313 extending beyond the first sponge 308 for providing a compression chamber 315 as described above. A drape 314 is placed over the collector assembly 304 and the tube 312. The drape 314 is folded over the tube 312 whereby same is spaced outwardly from the skin, thus providing an effective, fluid-tight seal around the tube 312., VII. Vacuum-Fixed Wound Therapy Method.
Fig. 10 shows a wound therapy method embodying the present invention. The method can be performed with one or more of the systems discussed above, including the vacuum-fixed dressings 3, 53, 102, 202 and 302. The method can also be performed with a wide variety of variations on the systems and dressings disclosed above.
VII. Fifth Modified Embodiment Wound Therapy And Tissue Management System 402.
Fig. 11 shows a wound therapy and tissue management system 402 comprising a fifth modified embodiment of the present invention. The system 402 includes a dressing 404 placed on a wound 406. Any of the dressing systems discussed above can be utilized.
The enclosure 414 is placed over the wound site 406 and includes an opening 416 extending therethrough and adapted for receiving a warming card 418 in covering relation thereover. The warming card 418 is operationally connected to a temperature control unit 420. A vacuum assisted closure unit 408 is fluidically connected to the enclosure 414 by a suitable suction tube and in turn is connected to a power source 410.
In operation, the warming card 418 is heated and raises the temperature within the enclosure 414 to promote healing. The vacuum assisted closure 408 functions as described above to remove effluent and to promote healing in cooperation with the warming card 418.
Warming cards and other components for use in connection with this embodiment of the invention are available from Augustine Medical Products, Inc.
IX. Sixth Modified Embodiment Wound Therapy and Tissue Management System 502.
Fig. 12 shows a wound therapy and tissue management system 502 comprising a sixth modified embodiment of the present invention. The system 502 is similar to the system 402 described above. A composite dressing 504 is comprised of first and second layers 506, 508. A
fluid source 518 communicates with a temperature control and pump unit 514 and provides influx to the system 502.
X. Seventh Modified Embodiment Wound Therapy and Tissue Management System 602.
Fig. 13 shows a wound therapy and tissue management system 602 comprising a seventh modified embodiment of the present invention. The system 602 is similar to the systems 402 and 502 described above. A transfer element 604 is covered by a drape 620, which mounts a film 616 adapted for receiving a warming card 618.
XI. Test Data Figs.14a-14d shows the results of tests performed with the dressing systems and methodologies discussed above and variations thereon. Fig. 14a shows system performance (time and temperature) with a dry PUE hydrophobic sponge material. Fig. 14b shows system performance with a wet PVA hydrophilic sponge material. Fig. 14c shows performance with an irrigated PUE hydrophobic sponge material with a warm-up plate (heating card) and a cover.
Fig. 14d shows system performance with both PUE hydrophobic sponge material and PVA
hydrophilic sponge material.
XII. Wound Therapy and Tissue Management System 702.
Figs. 15 and 16 show a wound therapy and tissue management system 702 comprising an eighth modified embodiment of the present invention. The system 702 is shown schematically in Fig. 15 and consists of inputs 704, the patient 706, outputs 708 and a feedback loop 710. The inputs 704 can comprise virtually any matter or energy deemed appropriate for the treatment protocol by the health-care practitioner. For example, various irrigation fluids, growth factors, antibiotics, anesthetics, etc. can be input to the patient 706. Still further, the inputs can comprise various forces and energy forms whereby a matter/energy gradient is established with respect to the patient 706.
For example, negative pressure from a suitable vacuum source (such as a VAC
unit available from Kinetic Concepts, Inc. of San Antonio, Texas) can be an input for creating a negative pressure gradient across the system. Likewise, positive pressure from a suitable fluid pump can be input to establish a positive pressure gradient across the system.
Other forces can provide electromagnetic, electrical, mechanical and thermal gradients.
The system 702 monitors performance of the patient 706 and controls the inputs interactively in response thereto. Parameters which could be monitored for feedback purposes included moisture levels, temperature, bacteria levels, fluid pressure, etc.
The presence or absence of particular elements and compounds can also be sensed, monitored and acted upon.
For example, is widely known that oxygen is an important factor in wound healing. Studies have shown that reepithelialization and collagen production are best achieved by varying the oxygen supply. Thus, the oxygen level within the enclosed, wound site environment can be monitored and the oxygen levels therein either increased or decreased as necessary to promote healing. Other controllable parameters include the pH factor and the moisture concentration of the wound environment. Various suitable monitoring means can be employed, including electronic sensors, visual indicators, color-change substances, etc.
The output from the patient can consist of fluid, such as effluent from the wound site, irrigation fluid removed in the process of flushing the wound site, and other matter and energy.
An important function of the system is the removal of toxins and bacteria, which can be flushed from the wound site in a liquid or fluid solution.
Fig. 16 is a block diagram of the system 702, showing the components thereof in greater detail. A programmable controller 712 can be preprogrammed to operate the system according to predetermined protocols. The controller 712 is connected to and controls the operation of the input source 714 and the gradient source 716. The input source 714 can comprise any suitable matter or energy for input to the system 702, including various fluids, medications, thermal energy, mechanical forces, temperature, etc., as discussed above. The gradient source is likewise unlimited. For example, pressure gradients (both positive and negative) are particularly suitable for controlling the operation of the system 702 for draining wounds.
Other types of gradients include temperature, osmotic, oncotic, pH, oxygen demand, bacteria concentrations, etc., as discussed above.
A gradient source 716 can comprise any suitable device for establishing a gradient. For example, a vacuum source can be utilized for creating a negative pressure gradient. A pump can be utilized for creating a positive pressure gradient. A drape 718 is placed in covering relation over a transfer element 720. The drape 718 can comprise any of the film materials discussed above and can be permeable, semi-permeable or impervious.
The transfer element 720 includes a first zone 720a with a first set of fluid flow characteristics and a second zone 720b with a second set of fluid flow characteristics. Such fluid flow characteristics can be a function of material, thickness, porosity, permeability, and sponge material attraction to proteins, fat cells and other substances. The zones 720a,b can be formed by providing layers of the material, by providing varying thicknesses, by interspersing a first material within a second material in predetermined configurations, etc. Still further, the first and second zones can be formed by subjecting the transfer element 720 to an electromagnetic field.
The first and second zones 7 20a,b can also be formed by varying the density of the transfer element 720, as indicated by the dashed line 732 (Fig. 16). Line 732 represents compressed material (e.g., foam) along one edge and expanded material in the second zone 720b. Such density gradients can be achieved by compressing the material or by heat-setting same in a manufacturing process. Transfer element 720 edges can also be compressed when the dressing is applied to achieve a desired density gradient. Material thickness can also be utilized to provide a flow coefficient gradient. In this case line 732 could represent a tapering of the transfer element 720 across the first and second zones 720a, 720b. A marbling effect with a material concentration gradient is shown at 733, with greater concentration along an edge and decreasing concentration towards interior portions of the transfer element 720, or vice-versa.
Constructing the first and second zones 720a, 720b of different materials with different respective flow coefficients could also achieve a desired flow gradient.
Medications and other substances can be applied to the transfer element materials to alter the flow characteristics thereof. Systemic agents 731 can be administered to the patient 726.
Fluid 722 can be introduced into the wound site 724 from the inputs 714 and its flow pathways can be controlled by the gradient source 716. For example, sponge materials with different flow characteristics can be configured to direct fluid (either gas or liquid) in predetermined flow patterns through the transfer element 720. Effluent 728 from the patient 726 is withdrawn from the wound site 724 and evacuated to a collection receptacle 730.
XII. Wound Therapy and Tissue Management Methodology Fig. 17 shows a flowchart for a wound therapy and tissue management methodology embodying the president mentioned. From Start 804, the method proceeds to Diagnose Patient Condition 806. Based on the diagnosis, a treatment protocols selected. The protocol includes an identification of gradients to be controlled by the methodology. For example, protocols involving vacuum-assisted wound drainage will generally include a negative pressure gradient.
Additional possible gradients are discussed above. It will be appreciated that virtually unlimited combinations of gradients can be formed in the system 702. Moreover, the timing of the gradient control can be varied as needed to achieve desired treatment results.
For example, collagen production and reepithelialization can be promoted by hyperbaric oxygen treatment procedures, such as alternating elevated and reduced oxygen concentrations.
Suction/compressive pressures can also be alternated to stimulate tissue growth.
Gradient sources are provided at 810 and can comprise vacuum/suction, fluids, medications, oxygen and various other matter and energy. Gradients can also be formed utilizing energy sources, such as thermal, mechanical force, etc. First and second transfer characteristics are selected at 812, 814 respectively. A transfer element(s) is provided at 816 and includes the transfer characteristics selected at 812, 814. The patient is prepared at 818.
Patient preparations can include any suitable medical procedures, such as debriding the wound, etc.
The transfer element is applied at 820 and draped at 822. The transfer element is connected to a gradient source at 824 and the gradient is applied at 826.
Fluid is transferred through the first transfer element zone at 828 and through the second transfer element zone at 830. It will be appreciated that such transfer zones can be adapted for directing the fluid along certain pathways to achieve desired results, such as evacuation of exudates.
The fluid is differentiated (e.g., liquids, gases or liquids and gases are separated) at 832.
The operating parameters are monitored at 834 and the gradient source(s) are adjusted accordingly add 836. Thereafter a"Continue?" decision box 838 is reached. If affirmative, the method returns to Apply Gradient 826 and operation continues with the adjusted gradient parameters. A negative decision at 838 leads to a termination of the procedure (i.e., "End") at 840.
XIV. Osmotic Gradient Wound Therapy and Tissue Management System 902 and Methodology.
Figs. 18-21 show a wound therapy and tissue management system 902 and methodology utilizing a controlled osmotic gradient. A patient 904 includes capillaries 906 which provide fluid, such as serum and blood, to a wound 908. Such fluid passes to the transfer element 910.
An air sump contro1914 communicates with the transfer element 910 through an air sump conduit 912. A discharge contro1918 communicates with the transfer element 910 through a discharge conduit 916. The controls 914,918 are interactively controlled by a controller 922, which is adapted to receive control input signals. Such input signals can comprise, for example, preprogrammed inputs, feedback signals (Fig. 15), etc. The input signals can origiiiate at sensors associated with the system 902 and with the patient 904. Such inputs can effectively conirol the osmotic gradient to achieve desired fluid, solvent and solute (e.g., toxin) transfers. For example, the primary external substance input can comprise:relatively dry ambient air.
Air movement through the system 902 tends to collect moisture for. discharge as water vapor.
The system 902 is covered by a drape 920, which can comprise various semi-permeable and impervious materials as required by fluid flow considerations and,various applications. For example, an impervious drape 920 tends -to block air from the system 902 and permit entry of same only through the air sump control 914.
Fig. 19 shows a hyperosmolar or air-sump system. Phase 1 represents a steady-state or increasing-toxin A condition and a concomitant increasing movement of toxin A
back into the patient. In phase 2 a hyperosmolar solution or air sump is introduced. This gradient draws fluid 15, from the capillaries to replace the fluid moved out of the wound into the transfer element carrying toxin A with it and decreasing movement of toxin A into the patient..
Alternatively or in addition; warmed irrigating fluid can be introduced into the -transfer element in phase 2. The advantages of warming the transfer element and wound site.in this manner include vasodilation, increase in cell motility and an increase in phagocytosis. For example, irrigating fluid warmed to approximately 40 degrees centigrade has been shown to remove the inhibitory effect of chronic wound fluid on cell culture motility and proliferation.
In phase 3, ongoing administration of this gradient continues these fluxes as water vapor is removed and dry air is sumped. Phase 4 results in a new steady-state condition with lower levels of toxin A in the wound (and the patient) and increased fluid and toxin A in the transfer element that is continuously evacuated.
Fig. 20 shows an isosmatic or isotonic flush or rinse methodology. In phase 1 there is a steady-state (or increasing toxin A level) condition with fluid (liquids) moving out from the wound to the transfer element being replaced by serum exudate from the capillary.
Evaporative loss from the transfer element is kept to a minimum by application of a drape material.
In phase 2, an isomatic rinse is introduced increasing the fluid content of the transfer element and decreasing the concentration of toxin A enabling a diffusion of toxin A from the wound into the transfer element. In phase 3, as this fluid is withdrawn, it also removes toxin A, enabling a continued diffusion of toxin A out of the wound. In phase 4, the resulting condition is fluid equilibrium and decreased concentration of toxin A in the wound.
As this situation revers to phase 1, the flush or rinse is repeated at intervals.
Fig. 21 shows a hypo-osmolar or heavy drape system. In phase 1 steady-state conditions generally exist with some evaporative loss of fluid (water vapor).
In phase 2, small amounts of hypo-osmolar fluid are introduced, or a cover/drape is placed over the transfer element with a heavy drape completely blocking evaporative loss, thus adding "free water" to the system. This reverses the outward flow of fluid from the wound.
In phase 3 this increased fluid in the wound allows the total amount of toxin A to also accumulate in the wound. In phase 4 this increase of fluid and toxin A in the wound without any egress produces movement of fluid (edema) and toxins (cellulitis) back into the patient and into the lumphatics.
Conclusion It is to be understood that while certain forms of the present invention have been illustrated and described herein, it is not to be limited to the specific forms or arrangement of parts described and shown.
Furthermore, it should be appreciated that divisional applications depending from this specification may be pending at the time this patent issues, the claims of which may encompass embodiments and applications not encompassed by the claims appended herein.
Accordingly, embodiments or elements disclosed in the specification but not literally claimed in the appended claims, if any, should not be presumed to be dedicated to the public.
Claims (20)
1. A fluid-differentiating wound therapy and tissue management system, which comprises:
(a) a fluid transfer element including:
(1) a non-attaching patient contact surface;
(2) a first zone with a first fluid transfer coefficient;
(3) a second zone with a second fluid transfer coefficient different from said first fluid transfer coefficient, said second zone being located adjacent to said first zone; and (4) a predetermined fluid flow path through said element guided by said fluid transfer coefficient differential between said first and second zones;
(b) a cover placed over said transfer element in contact therewith and including adhesive adapted for adhering said cover to a patient around the perimeter of said fluid transfer element;
(c) a gradient source for creating a gradient across said transfer element whereby fluids are moved through said transfer element;
(d) an effluent conduit connected to said transfer element and adapted for discharging effluent from the system; and (e) said predetermined fluid flow path being towards said effluent conduit.
(a) a fluid transfer element including:
(1) a non-attaching patient contact surface;
(2) a first zone with a first fluid transfer coefficient;
(3) a second zone with a second fluid transfer coefficient different from said first fluid transfer coefficient, said second zone being located adjacent to said first zone; and (4) a predetermined fluid flow path through said element guided by said fluid transfer coefficient differential between said first and second zones;
(b) a cover placed over said transfer element in contact therewith and including adhesive adapted for adhering said cover to a patient around the perimeter of said fluid transfer element;
(c) a gradient source for creating a gradient across said transfer element whereby fluids are moved through said transfer element;
(d) an effluent conduit connected to said transfer element and adapted for discharging effluent from the system; and (e) said predetermined fluid flow path being towards said effluent conduit.
2. The system according to claim 1, which includes:
(a) said gradient source comprising a pressure gradient source.
(a) said gradient source comprising a pressure gradient source.
3. The system according to claim 2, which includes:
(a) said pressure gradient source comprising a vacuum source for creating a negative pressure gradient across said transfer element.
(a) said pressure gradient source comprising a vacuum source for creating a negative pressure gradient across said transfer element.
4. The system according to claim 2, which includes:
(a) said pressure gradient source including a pump communicating with said transfer element and adapted for creating a positive pressure across same.
(a) said pressure gradient source including a pump communicating with said transfer element and adapted for creating a positive pressure across same.
5. The system according to claim 1, which includes:
(a) an inlet conduit connected to said transfer element and to said gradient source.
(a) an inlet conduit connected to said transfer element and to said gradient source.
6. The system according to claim 1, wherein said cover comprises a draped material adhesively mounted on the patient around the wound site.
7. The system according to claim 1, wherein said first zone comprises a first layer of sponge material and said second zone comprises a second layer of sponge material, said first and second sponge material layers comprising first second sponge materials with different flow characteristics.
8. The system according to claim 1, wherein said first zone comprises a first sponge material with a first set of fluid flow characteristics and said second zone comprises a second sponge material with a second set of fluid flow characteristics.
9. The system according to claim 8, wherein said first sponge material is intermingled with said second sponge material.
10. The system according to claim 1, wherein said gradient comprises a temperature gradient.
11. The system according to claim 1, wherein said gradient comprises an oxygen concentration gradient.
12. The system according to claim 1, wherein said gradient comprises a fluid concentration gradient.
13. The system according to claim 1, wherein said gradient comprises an oncotic gradient.
14. The system according to claim 1, wherein said gradient comprises an osmotic gradient.
15. The system according to claim 1, which includes:
(a) a programmable controller adapted for controlling the operation of the gradient.
(a) a programmable controller adapted for controlling the operation of the gradient.
16. The system according to claim 15, wherein said controller is programmed for automatically varying said gradient over time.
17. The system according to claim 1, which includes a conduit with multiple passages connected to said transfer element, each said passage being connected to a respective input or output associated with a gradient source.
18. The system according to claim 1, which includes:
(a) an input to said transfer element with both active and passive operational modes; and (b) an output from said transfer element with both active and passive operational modes.
(a) an input to said transfer element with both active and passive operational modes; and (b) an output from said transfer element with both active and passive operational modes.
19. The system according to claim 1, which includes:
(a) a monitor associated with said transfer element and adapted for monitoring said gradient;
(b) a feedback loop from said bottom tier to said controller, said feedback loop being adapted for controlling said gradient in response to patient conditions.
(a) a monitor associated with said transfer element and adapted for monitoring said gradient;
(b) a feedback loop from said bottom tier to said controller, said feedback loop being adapted for controlling said gradient in response to patient conditions.
20. A fluid-differentiating wound therapy and tissue management system, which comprises:
(a) a fluid transfer element including:
(1) a patient contact surface;
(2) a first zone with a first fluid transfer coefficient;
(3) a second zone with a second fluid transfer coefficient different from said first fluid transfer coefficient, said second zone being located adjacent to said first zone; and (4) a predetermined fluid flow path through said element guided by said fluid transfer coefficient differential between said first and second zones;
(b) a cover placed over said transfer element in contact therewith and adapted for contact with the patient around the perimeter of said fluid transfer element;
(c) a gradient source for creating an oncotic gradient across said transfer element; and (d) an effluent conduit connected to said transfer element and adapted for discharging effluent from the system.
(a) a fluid transfer element including:
(1) a patient contact surface;
(2) a first zone with a first fluid transfer coefficient;
(3) a second zone with a second fluid transfer coefficient different from said first fluid transfer coefficient, said second zone being located adjacent to said first zone; and (4) a predetermined fluid flow path through said element guided by said fluid transfer coefficient differential between said first and second zones;
(b) a cover placed over said transfer element in contact therewith and adapted for contact with the patient around the perimeter of said fluid transfer element;
(c) a gradient source for creating an oncotic gradient across said transfer element; and (d) an effluent conduit connected to said transfer element and adapted for discharging effluent from the system.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/135,741 | 2002-04-30 | ||
US10/135,741 US7108683B2 (en) | 2001-04-30 | 2002-04-30 | Wound therapy and tissue management system and method with fluid differentiation |
PCT/US2003/013829 WO2003092620A2 (en) | 2002-04-30 | 2003-04-30 | Wound therapy and tissue treatment management system and method with fluid differentiation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2483654A1 CA2483654A1 (en) | 2003-11-13 |
CA2483654C true CA2483654C (en) | 2008-08-05 |
Family
ID=29399226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2483654 Expired - Lifetime CA2483654C (en) | 2002-04-30 | 2003-04-30 | Wound therapy and tissue treatment management system and method with fluid differentiation |
Country Status (8)
Country | Link |
---|---|
US (1) | US7108683B2 (en) |
EP (1) | EP1513478B1 (en) |
AT (1) | ATE451897T1 (en) |
AU (1) | AU2003232043B2 (en) |
CA (1) | CA2483654C (en) |
DE (1) | DE60330557D1 (en) |
TW (1) | TWI227147B (en) |
WO (1) | WO2003092620A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8663200B2 (en) | 2006-10-13 | 2014-03-04 | Bluesky Medical Group Inc. | Control circuit and method for negative pressure wound treatment apparatus |
Families Citing this family (318)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9119705B2 (en) * | 1998-06-08 | 2015-09-01 | Thermotek, Inc. | Method and system for thermal and compression therapy relative to the prevention of deep vein thrombosis |
US6458109B1 (en) | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US6764462B2 (en) | 2000-11-29 | 2004-07-20 | Hill-Rom Services Inc. | Wound treatment apparatus |
US6824533B2 (en) | 2000-11-29 | 2004-11-30 | Hill-Rom Services, Inc. | Wound treatment apparatus |
PL203787B1 (en) | 2000-05-22 | 2009-11-30 | Coffey Arthur C | Combination sis and vacuum bandage and method |
US6685681B2 (en) | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6855135B2 (en) | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US7645269B2 (en) * | 2001-04-30 | 2010-01-12 | Kci Licensing, Inc. | Gradient wound treatment system and method |
US7364565B2 (en) * | 2001-07-27 | 2008-04-29 | Ramot At Tel Aviv University Ltd. | Controlled enzymatic removal and retrieval of cells |
US7004915B2 (en) * | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
CA2462877A1 (en) | 2001-10-11 | 2003-04-17 | Hill-Rom Services, Inc. | Waste container for negative pressure therapy |
CA2468309A1 (en) | 2001-12-26 | 2003-07-17 | Robert Petrosenko | Wound vacuum therapy dressing kit |
ATE387919T1 (en) | 2001-12-26 | 2008-03-15 | Hill Rom Services Inc | VACUUM BAND PACKAGING |
WO2003057070A2 (en) | 2001-12-26 | 2003-07-17 | Hill-Rom Services Inc. | Vented vacuum bandage and method |
EP1496822B1 (en) | 2002-04-10 | 2018-08-29 | KCI Medical Resources | Access openings in vacuum bandage |
AU2002359833A1 (en) | 2002-08-21 | 2004-03-11 | Hill-Rom Services, Inc. | Wound packing for preventing wound closure |
US8062331B2 (en) | 2002-08-21 | 2011-11-22 | Kci Licensing, Inc. | Internal and external medical closure screen systems and methods |
US7381211B2 (en) | 2002-08-21 | 2008-06-03 | Kci Licensing, Inc. | Medical closure screen device and method |
US7413570B2 (en) * | 2002-08-21 | 2008-08-19 | Kci Licensing, Inc. | Medical closure screen installation systems and methods |
US7413571B2 (en) * | 2002-08-21 | 2008-08-19 | Kci Licensing, Inc. | Flexible medical closure screen and method |
US7410495B2 (en) * | 2002-08-21 | 2008-08-12 | Kci Licensing, Inc. | Medical closure clip system and method |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US6979324B2 (en) * | 2002-09-13 | 2005-12-27 | Neogen Technologies, Inc. | Closed wound drainage system |
US7520872B2 (en) * | 2002-09-13 | 2009-04-21 | Neogen Technologies, Inc. | Closed wound drainage system |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
US6951553B2 (en) * | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
US10363344B2 (en) | 2002-12-31 | 2019-07-30 | Kci Licensing, Inc. | Externally-applied patient interface system and method with a controlled region for implanted or buried bio-reactor |
US8574278B2 (en) | 2006-05-09 | 2013-11-05 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
US8100956B2 (en) * | 2006-05-09 | 2012-01-24 | Thermotek, Inc. | Method of and system for thermally augmented wound care oxygenation |
US8778005B2 (en) | 2003-07-18 | 2014-07-15 | Thermotek, Inc. | Method and system for thermal and compression therapy relative to the prevention of deep vein thrombosis |
US8128672B2 (en) | 2006-05-09 | 2012-03-06 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
WO2005007060A2 (en) * | 2003-07-18 | 2005-01-27 | Thermotek, Inc. | Compression sequenced thermal therapy system |
CN1822874B (en) * | 2003-07-22 | 2010-10-13 | 凯希特许有限公司 | Negative pressure wound treatment dressing |
US20100210986A1 (en) * | 2003-07-22 | 2010-08-19 | Sanders T Blane | Negative pressure wound treatment dressings and systems |
US7361184B2 (en) * | 2003-09-08 | 2008-04-22 | Joshi Ashok V | Device and method for wound therapy |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
GB0518804D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Exudialysis tissue cleanser |
GB0409443D0 (en) * | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
GB0518825D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Apparatus with actives from tissue - sai |
US11298453B2 (en) | 2003-10-28 | 2022-04-12 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
GB0518826D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Apparatus with actives from tissue - exudialysis |
GB0325130D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with scaffold |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
US8758313B2 (en) | 2003-10-28 | 2014-06-24 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
US7128735B2 (en) | 2004-01-02 | 2006-10-31 | Richard Scott Weston | Reduced pressure wound treatment appliance |
US8100887B2 (en) | 2004-03-09 | 2012-01-24 | Bluesky Medical Group Incorporated | Enclosure-based reduced pressure treatment system |
US20050220821A1 (en) * | 2004-03-31 | 2005-10-06 | Allergan, Inc. | Pressure sore treatment |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7776028B2 (en) | 2004-04-05 | 2010-08-17 | Bluesky Medical Group Incorporated | Adjustable overlay reduced pressure wound treatment system |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7708724B2 (en) | 2004-04-05 | 2010-05-04 | Blue Sky Medical Group Incorporated | Reduced pressure wound cupping treatment system |
US7951124B2 (en) * | 2004-04-13 | 2011-05-31 | Boehringer Technologies, Lp | Growth stimulating wound dressing with improved contact surfaces |
US7884258B2 (en) | 2004-04-13 | 2011-02-08 | Boehringer Technologies, L.P. | Wound contact device |
US20050268425A1 (en) * | 2004-04-20 | 2005-12-08 | Clemons William E Sr | Surface cleaner |
GB0508528D0 (en) * | 2005-04-27 | 2005-06-01 | Smith & Nephew | SAI with macrostress |
GB0508531D0 (en) | 2005-04-27 | 2005-06-01 | Smith & Nephew | Sai with ultrasound |
GB0508529D0 (en) * | 2005-04-27 | 2005-06-01 | Smith & Nephew | Sai with microstress |
US10413644B2 (en) | 2004-04-27 | 2019-09-17 | Smith & Nephew Plc | Wound treatment apparatus and method |
GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
GB0409444D0 (en) * | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
GB0424046D0 (en) * | 2004-10-29 | 2004-12-01 | Smith & Nephew | Apparatus |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
US7998125B2 (en) | 2004-05-21 | 2011-08-16 | Bluesky Medical Group Incorporated | Hypobaric chamber treatment system |
USD679023S1 (en) | 2004-07-19 | 2013-03-26 | Thermotek, Inc. | Foot wrap |
US10765785B2 (en) | 2004-07-19 | 2020-09-08 | Thermotek, Inc. | Wound care and infusion method and system utilizing a therapeutic agent |
US10016583B2 (en) | 2013-03-11 | 2018-07-10 | Thermotek, Inc. | Wound care and infusion method and system utilizing a thermally-treated therapeutic agent |
US20060034053A1 (en) * | 2004-08-12 | 2006-02-16 | Thermotek, Inc. | Thermal control system for rack mounting |
US7612247B2 (en) * | 2004-09-29 | 2009-11-03 | Oyaski Michael F | Wound alternative treatment system |
SE0500061L (en) | 2005-01-11 | 2006-07-12 | Moelnlycke Health Care Ab | Sealing film dressing |
DE102005026771B4 (en) | 2005-06-10 | 2007-04-19 | Erdmann, Alfons, Dr. med. | Device for treating patients suffering from skin lesions distributed on the skin surface as well as body coverage |
US7981095B2 (en) * | 2005-07-18 | 2011-07-19 | Tearscience, Inc. | Methods for treating meibomian gland dysfunction employing fluid jet |
US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
US8950405B2 (en) * | 2006-05-15 | 2015-02-10 | Tearscience, Inc. | Treatment of obstructive disorders of the eye or eyelid |
US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
WO2013003594A2 (en) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Methods and systems for treating meibomian gland dysfunction using radio-frequency energy |
US8083787B2 (en) | 2005-07-18 | 2011-12-27 | Tearscience, Inc. | Method and apparatus for treating meibomian gland dysfunction |
US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
AU2005330067B1 (en) * | 2005-07-24 | 2006-12-14 | Carmeli Adahan | Wound closure and drainage system |
JP2009502301A (en) * | 2005-07-24 | 2009-01-29 | カーメリ・アダハン | Suction system, method and kit |
US7503910B2 (en) * | 2006-02-01 | 2009-03-17 | Carmeli Adahan | Suctioning system, method and kit |
EP2127690B2 (en) | 2005-07-24 | 2017-06-14 | M.E.A.C. Engineering Ltd. | Wound closure and drainage system |
CN101257875A (en) * | 2005-09-06 | 2008-09-03 | 泰科保健集团有限合伙公司 | Self contained wound dressing with micropump |
BRPI0616591A2 (en) | 2005-09-07 | 2011-06-28 | Tyco Healthcare | independent wound dressing apparatus |
BRPI0615765A2 (en) | 2005-09-07 | 2011-05-24 | Tyco Healthcare | vacuum reservoir wound dressing |
US20070065545A1 (en) * | 2005-09-20 | 2007-03-22 | Terry Vovan | Multi-topping tray container system |
US7648488B2 (en) | 2005-11-21 | 2010-01-19 | Pioneer Technology, Llc | Wound care system |
GB0524027D0 (en) * | 2005-11-25 | 2006-01-04 | Smith & Nephew | Fibrous dressing |
US8852149B2 (en) | 2006-04-06 | 2014-10-07 | Bluesky Medical Group, Inc. | Instructional medical treatment system |
US20100210982A1 (en) * | 2006-04-11 | 2010-08-19 | Niran Balachandran | Method And System For Providing Segmental Gradient Compression |
US7615036B2 (en) * | 2006-05-11 | 2009-11-10 | Kalypto Medical, Inc. | Device and method for wound therapy |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
US8338402B2 (en) * | 2006-05-12 | 2012-12-25 | Smith & Nephew Plc | Scaffold |
US8137390B2 (en) | 2006-05-15 | 2012-03-20 | Tearscience, Inc. | System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction |
US9314369B2 (en) * | 2006-05-15 | 2016-04-19 | Tearscience, Inc. | System for inner eyelid treatment of meibomian gland dysfunction |
US8128673B2 (en) | 2006-05-15 | 2012-03-06 | Tearscience, Inc. | System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction |
US8128674B2 (en) | 2006-05-15 | 2012-03-06 | Tearscience, Inc. | System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction |
SE0601536L (en) * | 2006-07-11 | 2008-01-12 | Moelnlycke Health Care Ab | Coil connection |
KR101523109B1 (en) * | 2006-09-26 | 2015-05-26 | 티 제이 스미스 앤드 네퓨 리미티드 | Lattice dressing |
US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
DE602007004546D1 (en) | 2006-09-28 | 2010-03-18 | Tyco Healthcare | Portable wound therapy system |
US8323264B2 (en) | 2006-10-17 | 2012-12-04 | Bluesky Medical Group, Inc. | Auxiliary powered negative pressure wound therapy apparatuses and methods |
US7967810B2 (en) * | 2006-10-20 | 2011-06-28 | Mary Beth Kelley | Sub-atmospheric wound-care system |
US7931651B2 (en) | 2006-11-17 | 2011-04-26 | Wake Lake University Health Sciences | External fixation assembly and method of use |
US8357130B2 (en) | 2006-11-21 | 2013-01-22 | Joshua David Smith | Wound care apparatus |
US8377016B2 (en) | 2007-01-10 | 2013-02-19 | Wake Forest University Health Sciences | Apparatus and method for wound treatment employing periodic sub-atmospheric pressure |
WO2008100437A1 (en) * | 2007-02-09 | 2008-08-21 | Kci Licensing Inc. | A breathable interface system for topical reduced pressure |
EP2129409B2 (en) * | 2007-03-14 | 2021-11-24 | The Board of Trustees of the Leland Stanford Junior University | Devices for application of reduced pressure therapy |
US8083712B2 (en) * | 2007-03-20 | 2011-12-27 | Neogen Technologies, Inc. | Flat-hose assembly for wound drainage system |
USD662214S1 (en) | 2007-04-10 | 2012-06-19 | Thermotek, Inc. | Circumferential leg wrap |
JP2010525916A (en) * | 2007-05-07 | 2010-07-29 | カルメリ アダハン | Suction system |
US9101357B2 (en) * | 2007-06-08 | 2015-08-11 | Board Of Trustees Of The University Of Arkansas | Physiologic abdominal closure |
SE531259C2 (en) | 2007-06-27 | 2009-02-03 | Moelnlycke Health Care Ab | Device for treating reduced pressure ulcers |
GB0712736D0 (en) * | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
GB0712737D0 (en) | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
GB0712764D0 (en) * | 2007-07-02 | 2007-08-08 | Smith & Nephew | Carrying Bag |
GB0712758D0 (en) * | 2007-07-02 | 2007-08-08 | Smith & Nephew | Battery recharging |
GB0712739D0 (en) * | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
US9408954B2 (en) | 2007-07-02 | 2016-08-09 | Smith & Nephew Plc | Systems and methods for controlling operation of negative pressure wound therapy apparatus |
GB0715259D0 (en) | 2007-08-06 | 2007-09-12 | Smith & Nephew | Canister status determination |
GB0712763D0 (en) | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
GB0715211D0 (en) | 2007-08-06 | 2007-09-12 | Smith & Nephew | Apparatus |
US7790946B2 (en) | 2007-07-06 | 2010-09-07 | Tyco Healthcare Group Lp | Subatmospheric pressure wound therapy dressing |
GB0715212D0 (en) * | 2007-08-06 | 2007-09-12 | Smith & Nephew | Apparatus |
BRPI0817544A2 (en) | 2007-10-10 | 2017-05-02 | Univ Wake Forest Health Sciences | apparatus for treating damaged spinal cord tissue |
WO2009049232A1 (en) | 2007-10-11 | 2009-04-16 | Spiracur, Inc. | Closed incision negative pressure wound therapy device and methods of use |
WO2009066106A1 (en) | 2007-11-21 | 2009-05-28 | Smith & Nephew Plc | Wound dressing |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
AU2008327660B2 (en) | 2007-11-21 | 2014-02-13 | Smith & Nephew Plc | Wound dressing |
ES2555204T3 (en) | 2007-11-21 | 2015-12-29 | T.J. Smith & Nephew Limited | Suction and bandage device |
GB0723875D0 (en) * | 2007-12-06 | 2008-01-16 | Smith & Nephew | Wound management |
GB0724039D0 (en) * | 2007-12-08 | 2008-01-16 | Smith & Nephew | Wound fillers |
US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB0723872D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus for topical negative pressure therapy |
GB0723852D0 (en) * | 2007-12-06 | 2008-01-16 | Smith & Nephew | Wound fillers |
US20130096518A1 (en) * | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB0723855D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus and method for wound volume measurement |
GB0723874D0 (en) * | 2007-12-06 | 2008-01-16 | Smith & Nephew | Dressing |
GB0724564D0 (en) * | 2007-12-18 | 2008-01-30 | Smith & Nephew | Portable wound therapy apparatus and method |
US8377017B2 (en) * | 2008-01-03 | 2013-02-19 | Kci Licensing, Inc. | Low-profile reduced pressure treatment system |
AU2009204140B9 (en) | 2008-01-08 | 2014-03-13 | Smith & Nephew Plc | Sustained variable negative pressure wound treatment and method of controlling same |
JP5925990B2 (en) | 2008-01-09 | 2016-05-25 | ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ | Device for treating damaged central nervous system tissue |
US8758419B1 (en) | 2008-01-31 | 2014-06-24 | Thermotek, Inc. | Contact cooler for skin cooling applications |
CA3001382C (en) | 2008-02-14 | 2020-10-27 | Spiracur Inc. | Devices and methods for treatment of damaged tissue |
GB0803564D0 (en) | 2008-02-27 | 2008-04-02 | Smith & Nephew | Fluid collection |
US9033942B2 (en) | 2008-03-07 | 2015-05-19 | Smith & Nephew, Inc. | Wound dressing port and associated wound dressing |
US8021347B2 (en) | 2008-07-21 | 2011-09-20 | Tyco Healthcare Group Lp | Thin film wound dressing |
US8298200B2 (en) | 2009-06-01 | 2012-10-30 | Tyco Healthcare Group Lp | System for providing continual drainage in negative pressure wound therapy |
EP2257320A2 (en) * | 2008-03-12 | 2010-12-08 | Bluesky Medical Group Inc. | Negative pressure dressing and method of using same |
US20090234306A1 (en) | 2008-03-13 | 2009-09-17 | Tyco Healthcare Group Lp | Vacuum wound therapy wound dressing with variable performance zones |
US9199012B2 (en) | 2008-03-13 | 2015-12-01 | Smith & Nephew, Inc. | Shear resistant wound dressing for use in vacuum wound therapy |
US8241260B2 (en) | 2008-04-21 | 2012-08-14 | Enzysurge Ltd. | Liquid streaming devices for treating wounds, method of making such devices, and method of using such devices for treating wounds |
US8048046B2 (en) * | 2008-05-21 | 2011-11-01 | Tyco Healthcare Group Lp | Wound therapy system with housing and canister support |
US8177763B2 (en) | 2008-09-05 | 2012-05-15 | Tyco Healthcare Group Lp | Canister membrane for wound therapy system |
US10912869B2 (en) | 2008-05-21 | 2021-02-09 | Smith & Nephew, Inc. | Wound therapy system with related methods therefor |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
US8414519B2 (en) | 2008-05-21 | 2013-04-09 | Covidien Lp | Wound therapy system with portable container apparatus |
JP5620906B2 (en) * | 2008-05-27 | 2014-11-05 | カリプト メディカル インコーポレーションKalypto Medical, Inc. | Control unit with a pump module for negative pressure type trauma treatment device |
JP2011521708A (en) * | 2008-05-27 | 2011-07-28 | カリプト メディカル インコーポレーション | Negative pressure trauma treatment device |
SE532493C2 (en) | 2008-05-29 | 2010-02-09 | Moelnlycke Health Care Ab | Wound dressing with two interconnected wound pads, suitable for use with compression dressings |
EP2281199B1 (en) * | 2008-06-04 | 2017-03-01 | KCI Licensing, Inc. | Detecting infection in reduced pressure wound treatment |
GB0811572D0 (en) * | 2008-06-24 | 2008-07-30 | Smith & Nephew | Negitive pressure wound theraphy device |
MX2010014304A (en) | 2008-06-26 | 2011-02-15 | Kci Licensing Inc | Stimulation of cartilage formation using reduced pressure treatment and chondrocytes. |
US8257326B2 (en) | 2008-06-30 | 2012-09-04 | Tyco Healthcare Group Lp | Apparatus for enhancing wound healing |
JP5571663B2 (en) | 2008-07-08 | 2014-08-13 | スミス アンド ネフュー インコーポレイテッド | Portable negative pressure wound therapy device |
CN102159139A (en) | 2008-07-18 | 2011-08-17 | 韦克福里斯特大学健康科学院 | Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage |
JP5502083B2 (en) | 2008-08-08 | 2014-05-28 | スミス アンド ネフュー インコーポレイテッド | Continuous fiber wound dressing |
US8827983B2 (en) | 2008-08-21 | 2014-09-09 | Smith & Nephew, Inc. | Sensor with electrical contact protection for use in fluid collection canister and negative pressure wound therapy systems including same |
US8216198B2 (en) | 2009-01-09 | 2012-07-10 | Tyco Healthcare Group Lp | Canister for receiving wound exudate in a negative pressure therapy system |
US8251979B2 (en) | 2009-05-11 | 2012-08-28 | Tyco Healthcare Group Lp | Orientation independent canister for a negative pressure wound therapy device |
US9414968B2 (en) | 2008-09-05 | 2016-08-16 | Smith & Nephew, Inc. | Three-dimensional porous film contact layer with improved wound healing |
CA2961078C (en) | 2008-09-18 | 2019-08-20 | Kci Licensing, Inc. | Multi-layer dressings, systems, and methods for applying reduced pressure at a tissue site |
US8158844B2 (en) | 2008-10-08 | 2012-04-17 | Kci Licensing, Inc. | Limited-access, reduced-pressure systems and methods |
EP3388093B1 (en) * | 2008-11-14 | 2020-05-20 | KCI Licensing, Inc. | Fluid pouch, system, and method for storing fluid from a tissue site |
EP2821095B1 (en) * | 2008-11-25 | 2017-08-09 | KCI Licensing, Inc. | Device for delivery of reduced pressure to body surfaces |
TWI384968B (en) * | 2008-12-11 | 2013-02-11 | Ind Tech Res Inst | Wound treatment apparatus |
CA2746515A1 (en) * | 2008-12-30 | 2010-07-08 | Kci Licensing, Inc. | Reduced pressure augmentation of microfracture procedures for cartilage repair |
MX2011007081A (en) | 2008-12-31 | 2011-07-28 | Kci Licensing Inc | System for providing fluid flow to nerve tissues. |
US8361043B2 (en) * | 2009-01-07 | 2013-01-29 | Spiracur Inc. | Reduced pressure therapy of the sacral region |
US7982087B2 (en) * | 2009-01-09 | 2011-07-19 | Smith & Nephew, Inc. | Wound dressing |
US8162907B2 (en) * | 2009-01-20 | 2012-04-24 | Tyco Healthcare Group Lp | Method and apparatus for bridging from a dressing in negative pressure wound therapy |
US8246591B2 (en) | 2009-01-23 | 2012-08-21 | Tyco Healthcare Group Lp | Flanged connector for wound therapy |
US8167869B2 (en) | 2009-02-10 | 2012-05-01 | Tyco Healthcare Group Lp | Wound therapy system with proportional valve mechanism |
GB0902368D0 (en) | 2009-02-13 | 2009-04-01 | Smith & Nephew | Wound packing |
GB0902816D0 (en) | 2009-02-19 | 2009-04-08 | Smith & Nephew | Fluid communication path |
WO2010102146A1 (en) * | 2009-03-04 | 2010-09-10 | Spiracur Inc. | Devices and methods to apply alternating level of reduced pressure to tissue |
US8882678B2 (en) * | 2009-03-13 | 2014-11-11 | Atrium Medical Corporation | Pleural drainage system and method of use |
US8444614B2 (en) * | 2009-04-10 | 2013-05-21 | Spiracur, Inc. | Methods and devices for applying closed incision negative pressure wound therapy |
CA2757841C (en) | 2009-04-10 | 2018-06-12 | Spiracur, Inc. | Methods and devices for applying closed incision negative pressure wound therapy |
EP2419157A4 (en) | 2009-04-17 | 2018-01-03 | Kalypto Medical, Inc. | Negative pressure wound therapy device |
US20110196321A1 (en) | 2009-06-10 | 2011-08-11 | Tyco Healthcare Group Lp | Fluid Collection Canister Including Canister Top with Filter Membrane and Negative Pressure Wound Therapy Systems Including Same |
US20100324516A1 (en) | 2009-06-18 | 2010-12-23 | Tyco Healthcare Group Lp | Apparatus for Vacuum Bridging and/or Exudate Collection |
TW201102118A (en) * | 2009-07-13 | 2011-01-16 | Univ Nat Pingtung Sci & Tech | A portable positive-bias caring device |
US8444613B2 (en) | 2009-07-14 | 2013-05-21 | Richard Vogel | Pump leak monitor for negative pressure wound therapy |
EP2461863B1 (en) * | 2009-08-05 | 2016-07-27 | Covidien LP | Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein |
WO2011043863A2 (en) | 2009-08-13 | 2011-04-14 | Michael Simms Shuler | Methods and dressing systems for promoting healing of injured tissue |
US8801685B2 (en) | 2009-12-22 | 2014-08-12 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US8066243B2 (en) | 2010-01-08 | 2011-11-29 | Richard C. Vogel | Adapter for portable negative pressure wound therapy device |
US8791315B2 (en) | 2010-02-26 | 2014-07-29 | Smith & Nephew, Inc. | Systems and methods for using negative pressure wound therapy to manage open abdominal wounds |
US8702665B2 (en) * | 2010-04-16 | 2014-04-22 | Kci Licensing, Inc. | Reduced-pressure sources, systems, and methods employing a polymeric, porous, hydrophobic material |
GB201006986D0 (en) | 2010-04-27 | 2010-06-09 | Smith & Nephew | Wound dressing |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
USRE48117E1 (en) | 2010-05-07 | 2020-07-28 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
USD692565S1 (en) | 2010-06-03 | 2013-10-29 | Smith & Nephew, Inc. | Organ protection layer |
US8753322B2 (en) | 2010-08-10 | 2014-06-17 | Spiracur Inc. | Controlled negative pressure apparatus and alarm mechanism |
US8795246B2 (en) | 2010-08-10 | 2014-08-05 | Spiracur Inc. | Alarm system |
GB201015656D0 (en) | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
US9408956B2 (en) | 2010-09-24 | 2016-08-09 | Kci Licensing, Inc. | Cellular control and tissue regeneration systems and methods |
CA3089920C (en) | 2010-10-12 | 2024-01-09 | Smith & Nephew, Inc. | A medical device configured to communicate with a remote computer system |
CA140189S (en) | 2010-10-15 | 2011-11-07 | Smith & Nephew | Medical dressing |
CA140188S (en) | 2010-10-15 | 2011-11-07 | Smith & Nephew | Medical dressing |
EP2643412B1 (en) | 2010-11-25 | 2016-08-17 | Smith & Nephew PLC | Composition i-ii and products and uses thereof |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
USD714433S1 (en) | 2010-12-22 | 2014-09-30 | Smith & Nephew, Inc. | Suction adapter |
RU2582866C2 (en) * | 2010-12-22 | 2016-04-27 | Смит Энд Нефью, Инк. | Device and method of wound healing with negative pressure |
WO2012083934A1 (en) * | 2010-12-23 | 2012-06-28 | Alfons Erdmann | Covering element with a sleeve body |
CN102068750B (en) * | 2011-01-26 | 2013-05-15 | 惠州市华阳医疗电子有限公司 | System equipment management-based negative pressure wound therapy system |
US9302034B2 (en) | 2011-04-04 | 2016-04-05 | Smith & Nephew, Inc. | Negative pressure wound therapy dressing |
WO2012142002A1 (en) * | 2011-04-12 | 2012-10-18 | Kci Licensing, Inc. | Evaporative fluid pouch and systems for use with body fluids |
GB201108229D0 (en) | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
US9058634B2 (en) | 2011-05-24 | 2015-06-16 | Kalypto Medical, Inc. | Method for providing a negative pressure wound therapy pump device |
RU2013157035A (en) | 2011-05-24 | 2015-06-27 | Калипто Медикал, Инк. | DEVICE WITH CONTROLLER AND PUMPING MODULES FOR PROVIDING NEGATIVE PRESSURE FOR TREATMENT OF RAS |
US9067003B2 (en) | 2011-05-26 | 2015-06-30 | Kalypto Medical, Inc. | Method for providing negative pressure to a negative pressure wound therapy bandage |
ES2610233T3 (en) | 2011-06-07 | 2017-04-26 | Smith & Nephew Plc | Members and methods for contacting wounds |
CN103857365B (en) | 2011-07-14 | 2017-06-23 | 史密夫及内修公开有限公司 | Wound dressing and treatment method |
US10512587B2 (en) | 2011-07-27 | 2019-12-24 | Thermotek, Inc. | Method and apparatus for scalp thermal treatment |
US9393354B2 (en) | 2011-11-01 | 2016-07-19 | J&M Shuler Medical, Inc. | Mechanical wound therapy for sub-atmospheric wound care system |
US9084845B2 (en) | 2011-11-02 | 2015-07-21 | Smith & Nephew Plc | Reduced pressure therapy apparatuses and methods of using same |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
DE102011121072A1 (en) * | 2011-12-09 | 2013-06-13 | Primed Halberstadt Medizintechnik Gmbh | Vacuum-assisted drainage system |
US9569566B2 (en) | 2011-12-12 | 2017-02-14 | Zam Research Llc | Simulation and control system and method using contact, pressure waves and factor controls for cell regeneration, tissue closure and related applications |
TW201328740A (en) * | 2012-01-11 | 2013-07-16 | Apex Medical Corp | Negative pressure wound care system with buffer unit |
JP6250571B2 (en) | 2012-03-12 | 2017-12-20 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Pressure reducing apparatus and method |
MX2014011314A (en) | 2012-03-20 | 2014-10-17 | Smith & Nephew | Controlling operation of a reduced pressure therapy system based on dynamic duty cycle threshold determination. |
EP2841121B1 (en) | 2012-04-24 | 2020-12-02 | Thermotek, Inc. | System for therapeutic use of ultra-violet light |
US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
AU346291S (en) | 2012-05-15 | 2013-01-09 | Smith & Nephew | Medical dressing |
WO2013175306A2 (en) | 2012-05-23 | 2013-11-28 | Smith & Nephew Plc | Apparatuses and methods for negative pressure wound therapy |
GB2502538B (en) * | 2012-05-29 | 2014-10-22 | Apex Medical Corp | Negative pressure wound therapy system with a buffering unit |
DK2879636T3 (en) | 2012-08-01 | 2017-06-19 | Smith & Nephew | Wound dressing |
EP3406231B1 (en) | 2012-08-01 | 2022-04-13 | Smith & Nephew plc | Wound dressing and method of treatment |
WO2014031857A2 (en) | 2012-08-22 | 2014-02-27 | Tearscience, Inc. | Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices |
EP3372208B1 (en) | 2012-11-12 | 2022-07-20 | 3M Innovative Properties Company | Externally-applied wound dressings and closures |
GB201317746D0 (en) | 2013-10-08 | 2013-11-20 | Smith & Nephew | PH indicator |
US20150190273A1 (en) * | 2013-01-11 | 2015-07-09 | Louis Causley Causley | Medical Device to Control Environmental Conditions for Surgical and Non-Surgical Wounds |
US20140257210A1 (en) * | 2013-02-20 | 2014-09-11 | Arnold R. Leiboff | Wound Management Method and Apparatus |
US10300180B1 (en) | 2013-03-11 | 2019-05-28 | Thermotek, Inc. | Wound care and infusion method and system utilizing a therapeutic agent |
USD764654S1 (en) | 2014-03-13 | 2016-08-23 | Smith & Nephew, Inc. | Canister for collecting wound exudate |
US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
BR112015020855A2 (en) | 2013-03-15 | 2017-07-18 | Smith & Nephew | wound dressing and treatment method |
US10695226B2 (en) | 2013-03-15 | 2020-06-30 | Smith & Nephew Plc | Wound dressing and method of treatment |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
EP2968871B8 (en) | 2013-03-15 | 2017-08-23 | KCI Licensing, Inc. | Topical vacuum-press surgical incisional dressings |
US10492956B2 (en) | 2013-03-15 | 2019-12-03 | Kci Licensing, Inc. | Topical vacuum-press surgical incisional dressings, surgical adjuncts, hybrids and composites |
CN116172656A (en) | 2013-03-15 | 2023-05-30 | 伊瑟拉医疗公司 | Vascular treatment devices and methods |
BR112015027696A2 (en) | 2013-05-10 | 2017-08-29 | Smith & Nephew | FLUID CONNECTOR FOR IRRIGATION AND ASPIRATION OF WOUNDS |
WO2017142874A2 (en) | 2016-02-16 | 2017-08-24 | Insera Therapeutics, Inc. | Aspiration devices and anchored flow diverting devices |
WO2015070144A1 (en) | 2013-11-11 | 2015-05-14 | Thermotek, Inc. | Method and system for wound care |
FR3015229B1 (en) * | 2013-12-19 | 2021-01-22 | Commissariat Energie Atomique | ARTICLE FOR ABSORBING A PHYSIOLOGICAL LIQUID, IN PARTICULAR DRESSING |
USD764047S1 (en) | 2014-05-28 | 2016-08-16 | Smith & Nephew, Inc. | Therapy unit assembly |
USD764048S1 (en) | 2014-05-28 | 2016-08-16 | Smith & Nephew, Inc. | Device for applying negative pressure to a wound |
USD764653S1 (en) | 2014-05-28 | 2016-08-23 | Smith & Nephew, Inc. | Canister for collecting wound exudate |
USD770173S1 (en) | 2014-06-02 | 2016-11-01 | Smith & Nephew, Inc. | Bag |
USD765830S1 (en) | 2014-06-02 | 2016-09-06 | Smith & Nephew, Inc. | Therapy unit assembly |
WO2015193257A1 (en) | 2014-06-18 | 2015-12-23 | Smith & Nephew Plc | Wound dressing |
US11007082B2 (en) * | 2014-07-23 | 2021-05-18 | Innovative Therapies Inc. | Foam laminate dressing |
AU2014402290B2 (en) | 2014-07-31 | 2020-05-21 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
WO2016044388A1 (en) | 2014-09-16 | 2016-03-24 | Leiboff Arnold | Wound management method and apparatus |
WO2016103032A1 (en) | 2014-12-22 | 2016-06-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus and methods |
EP3244852B1 (en) | 2015-01-14 | 2018-10-31 | KCI Licensing, Inc. | Closed abdominal manifold dressing |
JP6743050B2 (en) | 2015-04-27 | 2020-08-19 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Pressure reducing device and method |
US10076594B2 (en) | 2015-05-18 | 2018-09-18 | Smith & Nephew Plc | Fluidic connector for negative pressure wound therapy |
US10583228B2 (en) | 2015-07-28 | 2020-03-10 | J&M Shuler Medical, Inc. | Sub-atmospheric wound therapy systems and methods |
CN108292529A (en) | 2015-10-07 | 2018-07-17 | 史密夫和内修有限公司 | System and method for application decompression treatment |
US11090196B2 (en) | 2015-12-30 | 2021-08-17 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
US10420847B2 (en) | 2015-12-30 | 2019-09-24 | University Of Kansas Medical Center Research Institute, Inc. | System and method for wound array variables evaluation (WAVE) |
CA3009878A1 (en) | 2015-12-30 | 2017-07-06 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
USD796735S1 (en) | 2016-02-29 | 2017-09-05 | Smith & Nephew Plc | Mount apparatus for portable negative pressure apparatus |
JP1586116S (en) | 2016-02-29 | 2017-09-19 | ||
US11771820B2 (en) | 2016-03-04 | 2023-10-03 | Smith & Nephew Plc | Negative pressure wound therapy apparatus for post breast surgery wounds |
CA3016484A1 (en) | 2016-03-07 | 2017-09-14 | Smith & Nephew Plc | Wound treatment apparatuses and methods with negative pressure source integrated into wound dressing |
CN107185056A (en) * | 2016-03-15 | 2017-09-22 | 上佑实业股份有限公司 | The manufacture method of negative pressure wound therapy group, wound dressing and wound dressing |
WO2017186771A1 (en) | 2016-04-26 | 2017-11-02 | Smith & Nephew Plc | Wound dressings and methods of use with integrated negative pressure source having a fluid ingress inhibition component |
CN109069711A (en) | 2016-05-03 | 2018-12-21 | 史密夫及内修公开有限公司 | System and method for driving negative pressure source in negative pressure treatment system |
US11096831B2 (en) | 2016-05-03 | 2021-08-24 | Smith & Nephew Plc | Negative pressure wound therapy device activation and control |
CN109069710B (en) | 2016-05-03 | 2022-04-12 | 史密夫及内修公开有限公司 | Optimizing power delivery to a negative pressure source in a negative pressure therapy system |
WO2017197357A1 (en) | 2016-05-13 | 2017-11-16 | Smith & Nephew Plc | Automatic wound coupling detection in negative pressure wound therapy systems |
AU2017315129B2 (en) | 2016-08-25 | 2022-10-27 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
US11369730B2 (en) | 2016-09-29 | 2022-06-28 | Smith & Nephew, Inc. | Construction and protection of components in negative pressure wound therapy systems |
AU2017336310B2 (en) | 2016-09-30 | 2022-12-08 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB2555584B (en) | 2016-10-28 | 2020-05-27 | Smith & Nephew | Multi-layered wound dressing and method of manufacture |
US11806217B2 (en) | 2016-12-12 | 2023-11-07 | Smith & Nephew Plc | Wound dressing |
CN110582257B (en) | 2017-03-08 | 2022-03-15 | 史密夫及内修公开有限公司 | Negative pressure wound therapy device control in the presence of fault conditions |
CN110612131B (en) | 2017-05-09 | 2023-05-16 | 史密夫及内修公开有限公司 | Redundant control for negative pressure wound therapy system |
AU2018285235B2 (en) | 2017-06-14 | 2023-11-02 | T.J.Smith & Nephew, Limited | Negative pressure wound therapy apparatus |
US11554051B2 (en) | 2017-06-30 | 2023-01-17 | T.J. Smith And Nephew, Limited | Negative pressure wound therapy apparatus |
US11712508B2 (en) | 2017-07-10 | 2023-08-01 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
US10780201B2 (en) | 2017-07-29 | 2020-09-22 | Edward D. Lin | Control apparatus and related methods for wound therapy delivery |
US10729826B2 (en) | 2017-07-29 | 2020-08-04 | Edward D. Lin | Wound cover apparatus and related methods of use |
US11559622B2 (en) | 2017-07-29 | 2023-01-24 | Edward D. Lin | Deformation resistant wound therapy apparatus and related methods of use |
US11712373B2 (en) | 2017-07-29 | 2023-08-01 | Edward D. Lin | Wound therapy apparatus with scar modulation properties and related methods |
GB201718070D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
EP3681550B1 (en) | 2017-09-13 | 2023-11-08 | Smith & Nephew PLC | Negative pressure wound treatment apparatuses |
GB201718014D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Dressing for negative pressure wound therapy with filter |
GB201718054D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods |
WO2019086332A1 (en) | 2017-11-01 | 2019-05-09 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718072D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
USD847864S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
GB201811449D0 (en) | 2018-07-12 | 2018-08-29 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
USD898925S1 (en) | 2018-09-13 | 2020-10-13 | Smith & Nephew Plc | Medical dressing |
GB201820668D0 (en) | 2018-12-19 | 2019-01-30 | Smith & Nephew Inc | Systems and methods for delivering prescribed wound therapy |
US20220288297A1 (en) * | 2019-07-17 | 2022-09-15 | Kci Licensing, Inc. | Wound dressing with multiple treatment zones |
US11160917B2 (en) | 2020-01-22 | 2021-11-02 | J&M Shuler Medical Inc. | Negative pressure wound therapy barrier |
CN111888534B (en) * | 2020-07-01 | 2023-01-10 | 中国人民解放军总医院第八医学中心 | Wound drainage leakage liquid collector |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1335846A (en) | 1917-11-02 | 1920-04-06 | Copper Products Company | Electrolytic process and product |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
DE2953373A1 (en) * | 1978-12-06 | 1981-01-08 | P Svedman | Device for treating tissues,for example skin |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4480638A (en) | 1980-03-11 | 1984-11-06 | Eduard Schmid | Cushion for holding an element of grafted skin |
US4297795A (en) | 1980-06-06 | 1981-11-03 | Vito Licari | Portable drying rack |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US4969880A (en) * | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
DE19722075C1 (en) * | 1997-05-27 | 1998-10-01 | Wilhelm Dr Med Fleischmann | Medication supply to open wounds |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
DE19844355A1 (en) * | 1998-09-28 | 2000-04-06 | Rainer E Sachse | Adhesive wound dressing of flexible, membrane like material penetrable by air comprises integrated device which drains wound secretions or produces reduced pressure, or can be connected to an external suction system |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
GB0011202D0 (en) * | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
PL203787B1 (en) * | 2000-05-22 | 2009-11-30 | Coffey Arthur C | Combination sis and vacuum bandage and method |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
-
2002
- 2002-04-30 US US10/135,741 patent/US7108683B2/en not_active Expired - Lifetime
-
2003
- 2003-04-30 TW TW092110170A patent/TWI227147B/en not_active IP Right Cessation
- 2003-04-30 DE DE60330557T patent/DE60330557D1/en not_active Expired - Lifetime
- 2003-04-30 AT AT03747654T patent/ATE451897T1/en not_active IP Right Cessation
- 2003-04-30 EP EP03747654A patent/EP1513478B1/en not_active Revoked
- 2003-04-30 CA CA 2483654 patent/CA2483654C/en not_active Expired - Lifetime
- 2003-04-30 AU AU2003232043A patent/AU2003232043B2/en not_active Expired
- 2003-04-30 WO PCT/US2003/013829 patent/WO2003092620A2/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8663200B2 (en) | 2006-10-13 | 2014-03-04 | Bluesky Medical Group Inc. | Control circuit and method for negative pressure wound treatment apparatus |
Also Published As
Publication number | Publication date |
---|---|
EP1513478A4 (en) | 2007-04-25 |
US7108683B2 (en) | 2006-09-19 |
TW200403087A (en) | 2004-03-01 |
AU2003232043B2 (en) | 2008-02-28 |
DE60330557D1 (en) | 2010-01-28 |
TWI227147B (en) | 2005-02-01 |
ATE451897T1 (en) | 2010-01-15 |
CA2483654A1 (en) | 2003-11-13 |
WO2003092620A2 (en) | 2003-11-13 |
EP1513478A2 (en) | 2005-03-16 |
AU2003232043A1 (en) | 2003-11-17 |
US20030050594A1 (en) | 2003-03-13 |
EP1513478B1 (en) | 2009-12-16 |
WO2003092620A3 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2483654C (en) | Wound therapy and tissue treatment management system and method with fluid differentiation | |
US7645269B2 (en) | Gradient wound treatment system and method | |
US6071267A (en) | Medical patient fluid management interface system and method | |
US20210015678A1 (en) | Customizable closed tissue site dressing for improved postoperative removal | |
US10932953B2 (en) | Reduced-pressure dressings, systems, and methods with evaporative devices | |
AU2017201597B2 (en) | Dressings, systems and methods for treating a tissue site | |
JP5267962B2 (en) | System providing continuous drainage in negative pressure wound therapy | |
US7540848B2 (en) | Negative pressure treatment system with heating and cooling provision | |
US8956335B2 (en) | Externaly-applied patient interface system and method | |
WO2018163093A9 (en) | A wound dressing for combined negative pressure and fluid delivery system | |
US20070118096A1 (en) | Wound care system | |
US10363344B2 (en) | Externally-applied patient interface system and method with a controlled region for implanted or buried bio-reactor | |
KR20080056207A (en) | Apparatus | |
JP2014237036A (en) | Apparatus and method for administering reduced pressure treatment to tissue site | |
AU2016277595B2 (en) | Open-cavity, reduced-pressure treatment devices and systems | |
AU2015258308B2 (en) | Open-cavity, reduced-pressure treatment devices and systems | |
WO2020263473A1 (en) | Dressing including differential lateral contraction capability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20230501 |